<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain</journal-id><journal-id journal-id-type="iso-abbrev">Brain</journal-id><journal-id journal-id-type="pmc-domain-id">719</journal-id><journal-id journal-id-type="pmc-domain">brain</journal-id><journal-id journal-id-type="publisher-id">brainj</journal-id><journal-title-group><journal-title>Brain</journal-title></journal-title-group><issn pub-type="ppub">0006-8950</issn><issn pub-type="epub">1460-2156</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10232261</article-id><article-id pub-id-type="pmcid-ver">PMC10232261.1</article-id><article-id pub-id-type="pmcaid">10232261</article-id><article-id pub-id-type="pmcaiid">10232261</article-id><article-id pub-id-type="pmid">36477471</article-id><article-id pub-id-type="doi">10.1093/brain/awac463</article-id><article-id pub-id-type="publisher-id">awac463</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00310</subject><subject>AcademicSubjects/SCI01870</subject></subj-group></article-categories><title-group><article-title>Case-control study developing Scottish Epilepsy Deaths Study Score to predict epilepsy-related death</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9588-2944</contrib-id><name name-style="western"><surname>Mbizvo</surname><given-names initials="GK">Gashirai K</given-names></name><aff>
<institution>Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4TJ</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool</institution>, <addr-line>Liverpool L69 7BE</addr-line>, <country country="GB">UK</country></aff><xref rid="awac463-cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schnier</surname><given-names initials="C">Christian</given-names></name><aff>
<institution>Usher Institute, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4UX</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Simpson</surname><given-names initials="CR">Colin R</given-names></name><aff>
<institution>Usher Institute, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4UX</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>School of Health, Wellington Faculty of Health, Victoria University of Wellington</institution>, <addr-line>Wellington 6140</addr-line>, <country country="NZ">New Zealand</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Duncan</surname><given-names initials="SE">Susan E</given-names></name><aff>
<institution>Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4TJ</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>Department of Clinical Neurosciences, NHS Lothian</institution>, <addr-line>Edinburgh EH16 4SA</addr-line>, <country country="GB">UK</country></aff><xref rid="awac463-FM1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chin</surname><given-names initials="RFM">Richard F M</given-names></name><aff>
<institution>Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4TJ</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>Royal Hospital for Children and Young People</institution>, <addr-line>Edinburgh EH16 4TJ</addr-line>, <country country="GB">UK</country></aff><xref rid="awac463-FM1" ref-type="author-notes"/></contrib></contrib-group><author-notes><corresp id="awac463-cor1">Correspondence to: Gashirai Mbizvo Muir Maxwell Epilepsy Centre University of Edinburgh Edinburgh BioQuarter, 50 Little France Crescent, Edinburgh EH16 4TJ, UK E-mail: <email>Gashirai.Mbizvo@ed.ac.uk</email></corresp><fn id="awac463-FM1"><p>Susan E Duncan and Richard F M Chin contributed equally to this work.</p></fn></author-notes><pub-date pub-type="collection"><month>6</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2022-12-07"><day>07</day><month>12</month><year>2022</year></pub-date><volume>146</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">437051</issue-id><fpage>2418</fpage><lpage>2430</lpage><history><date date-type="received"><day>16</day><month>3</month><year>2022</year></date><date date-type="rev-recd"><day>29</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>11</month><year>2022</year></date><date date-type="corrected-typeset"><day>15</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>12</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-06-01 11:25:15.820"><day>01</day><month>06</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="awac463.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="awac463.pdf"/><abstract><title>Abstract</title><p>This study aimed to develop a risk prediction model for epilepsy-related death in adults.</p><p>In this age- and sex-matched case-control study, we compared adults (aged &#8805;16 years) who had epilepsy-related death between 2009 and 2016 to living adults with epilepsy in Scotland. Cases were identified from validated administrative national datasets linked to mortality records. ICD-10 cause-of-death coding was used to define epilepsy-related death. Controls were recruited from a research database and epilepsy clinics. Clinical data from medical records were abstracted and used to undertake univariable and multivariable conditional logistic regression to develop a risk prediction model consisting of four variables chosen <italic toggle="yes">a priori</italic>. A weighted sum of the factors present was taken to create a risk index&#8212;the Scottish Epilepsy Deaths Study Score. Odds ratios were estimated with 95% confidence intervals (CIs).</p><p>Here, 224 deceased cases (mean age 48 years, 114 male) and 224 matched living controls were compared. In univariable analysis, predictors of epilepsy-related death were recent epilepsy-related accident and emergency attendance (odds ratio 5.1, 95% CI 3.2&#8211;8.3), living in deprived areas (odds ratio 2.5, 95% CI 1.6&#8211;4.0), developmental epilepsy (odds ratio 3.1, 95% CI 1.7&#8211;5.7), raised Charlson Comorbidity Index score (odds ratio 2.5, 95% CI 1.2&#8211;5.2), alcohol abuse (odds ratio 4.4, 95% CI 2.2&#8211;9.2), absent recent neurology review (odds ratio 3.8, 95% CI 2.4&#8211;6.1) and generalized epilepsy (odds ratio 1.9, 95% CI 1.2&#8211;3.0). Scottish Epilepsy Deaths Study Score model variables were derived from the first four listed before, with Charlson Comorbidity Index &#8805;2 given 1 point, living in the two most deprived areas given 2 points, having an inherited or congenital aetiology or risk factor for developing epilepsy given 2 points and recent epilepsy-related accident and emergency attendance given 3 points. Compared to having a Scottish Epilepsy Deaths Study Score of 0, those with a Scottish Epilepsy Deaths Study Score of 1 remained low risk, with odds ratio 1.6 (95% CI 0.5&#8211;4.8). Those with a Scottish Epilepsy Deaths Study Score of 2&#8211;3 had moderate risk, with odds ratio 2.8 (95% CI 1.3&#8211;6.2). Those with a Scottish Epilepsy Deaths Study Score of 4&#8211;5 and 6&#8211;8 were high risk, with odds ratio 14.4 (95% CI 5.9&#8211;35.2) and 24.0 (95% CI 8.1&#8211;71.2), respectively.</p><p>The Scottish Epilepsy Deaths Study Score may be a helpful tool for identifying adults at high risk of epilepsy-related death and requires external validation.</p></abstract><abstract abstract-type="teaser"><p>Mbizvo <italic toggle="yes">et al</italic>. develop the SEDS Score: a risk prediction model to identify adults at high risk of epilepsy-related death. Individuals with a SEDS Score of 1 remain at low risk; those with scores of 2&#8211;3 have moderately increased risk; while scores of 4&#8211;5 and 6&#8211;8 reflect high risk, with 14- and 24-times increased risk, respectively.</p></abstract><kwd-group><kwd>cause of death</kwd><kwd>seizures</kwd><kwd>risk prediction modelling</kwd><kwd>routine data</kwd><kwd>terminal illness</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Epilepsy Research UK</institution><institution-id institution-id-type="DOI">10.13039/501100000295</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>R44007</institution></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Juliet Bergqvist Memorial Fund</institution></institution-wrap></funding-source></award-group></funding-group><counts><page-count count="13"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="awac463-s0"><title>Introduction</title><p>Epilepsy is common, affecting 70 million people globally.<sup><xref rid="awac463-B1" ref-type="bibr">1</xref></sup> In the UK, there are 600 000 people with epilepsy, of which 60 000 live in Scotland.<sup><xref rid="awac463-B2" ref-type="bibr">2</xref></sup> The 5.4 million population of Scotland is roughly 8% that of the UK. People with epilepsy are at significantly increased risk of premature death.<sup><xref rid="awac463-B3" ref-type="bibr">3</xref></sup> Some of those deaths may be entirely unrelated to their epilepsy. However, a substantial proportion relate to the epilepsy itself, its treatment or comorbidities associated with epilepsy.<sup><xref rid="awac463-B3" ref-type="bibr">3</xref></sup> Together, these are termed &#8216;epilepsy-related deaths&#8217;, and they are likely to contribute a significant burden of total years of potential life lost.<sup><xref rid="awac463-B3" ref-type="bibr">3</xref>,<xref rid="awac463-B4" ref-type="bibr">4</xref></sup> A recent study of 1921 epilepsy-related deaths identified across Scotland between 2009 and 2016 showed that these have remained high over time, with age-specific mortality ratios significantly increased in young adults aged 16&#8211;54 years, peaking at 5.3 [95% confidence interval (CI) 1.8&#8211;8.8] in those aged 16&#8211;24 years.<sup><xref rid="awac463-B5" ref-type="bibr">5</xref></sup> Sudden unexpected death in epilepsy (SUDEP) constituted 30% of the 553 young adult epilepsy-related deaths, with several other non-SUDEP fatal mechanisms identified including aspiration pneumonia, cardiac arrest, antiseizure medication (ASM) or narcotic poisoning, drowning and alcohol dependence. A substantial number of these young adult epilepsy-related deaths were potentially avoidable,<sup><xref rid="awac463-B5" ref-type="bibr">5</xref></sup> as has also been suggested in other countries.<sup><xref rid="awac463-B6" ref-type="bibr">6&#8211;8</xref></sup> This highlights the importance of trying to identify those individuals who are at highest risk so they can be targeted with earlier and more aggressive care. Few studies have attempted to do this through risk prediction modelling (RPM), particularly focusing on epilepsy-related deaths specifically.<sup><xref rid="awac463-B9" ref-type="bibr">9&#8211;14</xref></sup> To help address this, we have undertaken a Scottish multicentre case-control study using routine clinical information gathered from medical records. The study aims to develop a pragmatic RPM to identify adults at increased risk of epilepsy-related death. We will describe multiple potential risk factors for epilepsy-related death to help build the model.</p></sec><sec sec-type="materials|methods" id="awac463-s1"><title>Materials and methods</title><sec id="awac463-s1.1"><title>Study design summary</title><p>We carried out an age- and sex-matched case-control study comparing adults who had epilepsy-related death to living adults with epilepsy. Data pertaining to potential risk factors for epilepsy-related death were collected from the medical records of cases and controls to allow multivariable analysis and development of an RPM. The study was designed for model development and internal validation,<sup><xref rid="awac463-B15" ref-type="bibr">15</xref></sup> and follows standard reporting guidelines.<sup><xref rid="awac463-B16" ref-type="bibr">16</xref></sup></p></sec><sec id="awac463-s1.2"><title>Data sources and participants</title><sec id="awac463-s1.2.1"><title>Case ascertainment</title><p>Cases were screened for inclusion from the dataset of a previous study investigating the diagnostic accuracy of four administrative healthcare datasets used to identify deceased adults with epilepsy in Scotland.<sup><xref rid="awac463-B17" ref-type="bibr">17</xref></sup> The study linked national mortality records, hospital admissions, ASM prescriptions and regional primary care attendances to identify adults (aged &#8805;16 years) who died between 1 January 2009 and 1 January 2016. Coded indicators of epilepsy were compared to confirmed epilepsy diagnoses made by a senior epileptologist upon reviewing medical records (see &#8216;Confirming epilepsy diagnosis&#8217; section). The study identified 614 confirmed epilepsy cases who had epilepsy-related death during the 2009&#8211;16 study period. Epilepsy-related death was defined as death occurring with at least one International Classification of Diseases (ICD)-10-coded cause listed as G40&#8211;41 (epilepsy&#8211;status epilepticus) and/or R56.8 (seizure) in any position within the sequence of events that lead to death in the mortality records, or with cause-of-death free texts pertaining to seizures (alongside at least one community-prescribed ASM), epilepsy or SUDEP.<sup><xref rid="awac463-B5" ref-type="bibr">5</xref>,<xref rid="awac463-B17" ref-type="bibr">17</xref></sup> Such a definition is consistent with national guidance that the presence of an epilepsy code/indicator anywhere in the cause-of-death record indicates that epilepsy was thought by the certifying doctor to be either part of the sequence of events leading to death or else a factor contributing to the death.<sup><xref rid="awac463-B18" ref-type="bibr">18</xref>,<xref rid="awac463-B19" ref-type="bibr">19</xref></sup> Additional case-ascertainment benefit was drawn from the routine cause-of-death quality assurance processes in place to improve the accuracy of Scottish death certification and coding,<sup><xref rid="awac463-B20" ref-type="bibr">20</xref>,<xref rid="awac463-B21" ref-type="bibr">21</xref></sup> the robustness of which was highlighted recently.<sup><xref rid="awac463-B22" ref-type="bibr">22</xref></sup> These quality assurance processes helped reduce the likelihood of there being an underestimation in the number of epilepsy-related deaths captured by the study,<sup><xref rid="awac463-B5" ref-type="bibr">5</xref>,<xref rid="awac463-B17" ref-type="bibr">17</xref></sup> which can sometimes happen in studies using death certification.</p></sec><sec id="awac463-s1.2.2"><title>Control ascertainment</title><p>Living control participants were screened for inclusion from a nationwide Scottish Health Research Register (SHARE),<sup><xref rid="awac463-B23" ref-type="bibr">23</xref>,<xref rid="awac463-B24" ref-type="bibr">24</xref></sup> supplemented by controls recruited directly from National Health Service (NHS) Lothian epilepsy clinics. Written consent was obtained from both groups.</p><p>The SHARE register consists of nearly 300 000 research volunteers in Scotland, aged &#8805;11 years.<sup><xref rid="awac463-B23" ref-type="bibr">23</xref>,<xref rid="awac463-B24" ref-type="bibr">24</xref></sup> The SHARE research staff connected us with SHARE registrants aged &#8805;16 years with at least one G40&#8211;41-ICD-10-coded activity in their health records and consenting to be contacted by us. We reviewed the medical records of those consenting to participate.</p><p>Clinic controls were recruited in a consecutive manner directly from NHS Lothian epilepsy clinics. We reviewed the medical records of those consenting to participate.</p><p>Eligible cases and controls required sufficiently complete medical records to allow confirmation of a diagnosis of epilepsy and abstraction of clinical data. Controls were matched 1:1 by age (&#177;10 years) and sex to cases of epilepsy-related death after recruitment.</p></sec><sec id="awac463-s1.2.3"><title>Confirming epilepsy diagnosis</title><p>Access to medical records was made possible through the support of a national network of clinical colleagues, as described in greater detail previously.<sup><xref rid="awac463-B5" ref-type="bibr">5</xref>,<xref rid="awac463-B17" ref-type="bibr">17</xref></sup> For each candidate case and control, the medical records were reviewed by an experienced consultant epileptologist (S.E.D.), who used the medical records to confirm the presence or absence of epilepsy.<sup><xref rid="awac463-B25" ref-type="bibr">25</xref></sup> This was based on corroborative evidence such as the presence of two or more unprovoked seizures or clear documentation of a diagnosis of epilepsy from a neurologist.<sup><xref rid="awac463-B26" ref-type="bibr">26</xref>,<xref rid="awac463-B27" ref-type="bibr">27</xref></sup> The medical records were extensive, and included electronic and paper records from general and/or specialist inpatients, emergency care, outpatients (including neurology clinics), hospital discharge summaries, referral letters from general practitioners, radiology scans, neurophysiology reports and medication lists.</p></sec><sec id="awac463-s1.2.4"><title>Data abstraction, outcome and predictors</title><p>The outcome for model prediction fell into binary categories: 1 = deceased (i.e. epilepsy-related death) and 0 = alive (living control).</p><p>Abstraction of data from medical records was undertaken by S.E.D. during several hospital visits made between 11 October 2017 and 24 February 2019 for cases, and 25 February 2019 and 15 January 2020 for controls. Data on multiple potential risk factors were collected using a data abstraction tool developed <italic toggle="yes">a priori</italic> using systematic review evidence (<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>, section 1).<sup><xref rid="awac463-B3" ref-type="bibr">3</xref></sup> Candidate predictor variable selection was refined by consensus among the research team and informed by consultation with external epilepsy specialists, patient and charity groups, and parliamentary policymakers.<sup><xref rid="awac463-B28" ref-type="bibr">28&#8211;30</xref></sup><xref rid="awac463-T1" ref-type="table">Table 1</xref> lists the predictor variables that were ultimately selected as candidates for model development. The Scottish Index of Multiple Deprivation (SIMD) looks at the extent to which an area is deprived across seven domains: income, employment, education, health, access to services, crime and housing. This is ranked from 1 = most deprived to 5 = least deprived areas of residence.<sup><xref rid="awac463-B32" ref-type="bibr">32</xref></sup> For each control participant, we inserted their home postcode into the Scottish Government&#8217;s publicly available SIMD postcode lookup file to reveal their SIMD quintile.<sup><xref rid="awac463-B32" ref-type="bibr">32</xref></sup> The Charlson Comorbidity Index (CCI) is a well-validated prognostic index of comorbid conditions that alter 10-year survival in patients with multiple comorbidities.<sup><xref rid="awac463-B33" ref-type="bibr">33&#8211;35</xref></sup> The comorbidities captured include cardiovascular, cerebrovascular, respiratory, neurodegenerative and neoplastic. The CCI is scored from 0 to 37 points, with higher scores associated with lower survival. We extracted each participant&#8217;s current comorbidities from the medical records and used this to calculate their CCI score, which is easily done using an online calculator (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci" ext-link-type="uri">www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci</ext-link>).<sup><xref rid="awac463-B36" ref-type="bibr">36</xref></sup> We grouped the CCI scores into categories 0&#8211;1 (associated with a 96&#8211;98% estimated 10-year survival), 2&#8211;3 (77&#8211;90% estimated 10-year survival) and &#8805;4 (&#8804;53% estimated 10-year survival),<sup><xref rid="awac463-B33" ref-type="bibr">33&#8211;35</xref></sup> as grouped elsewhere.<sup><xref rid="awac463-B31" ref-type="bibr">31</xref></sup> However, we were unable to include age within our CCI calculations as cases and controls were already 1:1 matched by age in our study, meaning our CCI scores took a maximum of 33 points. CCI scores were used as they would allow us to capture the comorbidities most relevant to mortality and increase applicability of our methods in other regions, as CCI is widely used.<sup><xref rid="awac463-B31" ref-type="bibr">31&#8211;38</xref></sup></p><table-wrap position="float" id="awac463-T1" orientation="portrait"><label>Table 1</label><caption><p>Variables considered for analysis (<italic toggle="yes">n</italic> = 224 deceased cases and 224 alive controls)</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variable</th><th align="center" rowspan="2" colspan="1">Coding</th><th align="center" colspan="2" rowspan="1">Missing data burden</th><th align="center" rowspan="2" colspan="1">Chosen for multivariable model</th></tr><tr><th align="left" rowspan="1" colspan="1">Cases</th><th align="center" rowspan="1" colspan="1">Controls</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SIMD quintile<sup>a</sup></td><td rowspan="1" colspan="1">Group 1 = 2 most deprived quintiles combined<break/>Group 2 = middle deprived quintile<break/>Group 3 = 2 least deprived quintiles combined</td><td rowspan="1" colspan="1">0%</td><td rowspan="1" colspan="1">3%</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">A&amp;E attendance or hospital admission for epilepsy/seizures in preceding 12 months</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">4%</td><td rowspan="1" colspan="1">1%</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">No risk factors for epilepsy<break/>Inherited/congenital/genetic/acquired early life<sup>b</sup><break/>Acquired later life<sup>c</sup><break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">13%</td><td rowspan="1" colspan="1">12%</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">CCI<sup>d</sup></td><td rowspan="1" colspan="1">0&#8211;1<break/>2&#8211;3 &#8805; 4<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">4%</td><td rowspan="1" colspan="1">13%</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">Alcohol abuse in preceding 24 months</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">11%</td><td rowspan="1" colspan="1">4%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Seizure type</td><td rowspan="1" colspan="1">Focal seizures &#177; secondary generalization<break/>Generalized seizures</td><td rowspan="1" colspan="1">20%</td><td rowspan="1" colspan="1">9%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Mental health problems in preceding 24 months<sup>e</sup></td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">16%</td><td rowspan="1" colspan="1">14%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Epilepsy surgery ever</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">7%</td><td rowspan="1" colspan="1">1%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Seen by neurologist in preceding 12 months</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">1%</td><td rowspan="1" colspan="1">1%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Number of ASMs when last seen</td><td rowspan="1" colspan="1">Not on an ASM<break/>1 ASM<break/>2 ASMs &#8805;3 ASM<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">0%</td><td rowspan="1" colspan="1">0%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Seizure frequency when last seen</td><td rowspan="1" colspan="1">&lt;1 seizure per year &#8805;1 seizure per year<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">40%</td><td rowspan="1" colspan="1">11%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Seizure timing</td><td rowspan="1" colspan="1">Mainly daytime<break/>Manly nocturnal<break/>Mixture of both daytime and nocturnal<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">70%</td><td rowspan="1" colspan="1">56%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Seizure alarm in place</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">60%</td><td rowspan="1" colspan="1">36%</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Status epilepticus in preceding 24 months</td><td rowspan="1" colspan="1">Yes<break/>No<break/>Unable to tell (missing data)</td><td rowspan="1" colspan="1">13%</td><td rowspan="1" colspan="1">1%</td><td rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><fn id="TN001"><p>A&amp;E = accident and emergency.</p></fn><fn id="TN002"><p>
<sup>a</sup>Socioeconomic deprivation markers splitting the population into quintiles ordered 1 (most deprived) to 5 (least deprived) areas of residence.</p></fn><fn id="TN003"><p>
<sup>b</sup>Inherited/congenital/genetic aetiologies or risk factors acquired at &lt;5 years of age: Febrile convulsions, first degree relative with epilepsy, congenital abnormality/malformation (e.g. cerebral palsy, metabolic infancy syndrome, birth hypoxia), genetic syndrome, attention deficit hyperactivity disorder, autism spectrum disorder, developmental/intellectual delay, premature birth, birth/perinatal difficulties, hydrocephalus, neonatal seizures, or the following acquired at &lt;5 years of age: meningitis/encephalitis, severe head injury, brain tumour, cerebrovascular disease, limbic encephalitis, brain surgery, CNS demyelinating disease, abnormal brain imaging, other hypoxic brain injury, neurodegenerative disease.</p></fn><fn id="TN004"><p>
<sup>c</sup>Risk factors acquired at &#8805; 5 years: History of meningitis/encephalitis, severe head injury, brain tumour, cerebrovascular disease, limbic encephalitis, brain surgery, CNS demyelinating disease, abnormal brain imaging, other hypoxic brain injury, neurodegenerative disease.</p></fn><fn id="TN005"><p>
<sup>d</sup>CCI: Predicts 10-year survival in patients with multiple comorbidities, accessible here: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci" ext-link-type="uri">www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci</ext-link>. Patients normally have a score of 0&#8211;37, although we did not include age within our CCI calculations as cases and controls were already 1:1 matched by age in our study. We chose the initial grouping based on recent literature.<sup><xref rid="awac463-B31" ref-type="bibr">31</xref></sup></p></fn><fn id="TN006"><p>
<sup>e</sup>Includes psychosis, depression, anxiety, contact with psychiatric/psychological/learning disability services, admission under psychiatry, self-harm/suicide attempts.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="awac463-s1.3"><title>Statistical analysis</title><p>All analyses were performed using IBM SPSS Statistics for Macintosh, v.25.0 (Armonk, NY, USA: IBM Corporation). Where relevant, categories with fewer than five events/participants were combined or reported as &#8216;&lt;5&#8217; to avoid patient identification.<sup><xref rid="awac463-B39" ref-type="bibr">39</xref></sup></p><sec id="awac463-s1.3.1"><title>Sample size</title><p>We estimated that we could capture a convenience sample size of 200&#8211;250 controls, matched to a mirrored number of age- and sex-matched cases taken from the 614 deceased adults who had epilepsy-related death, for whom medical records had already been reviewed during the diagnostic accuracy study.<sup><xref rid="awac463-B17" ref-type="bibr">17</xref></sup> This number of controls was based on our estimated capacity and the time taken to fully recruit living controls and abstract their clinical data from medical records. Using a recommended rule of 50 events per variable for logistic regression to estimate coefficients with adequate precision,<sup><xref rid="awac463-B40" ref-type="bibr">40</xref>,<xref rid="awac463-B41" ref-type="bibr">41</xref></sup> such a sample size would allow for a multivariable RPM size of four predictor variables. Using more variables than the sample data could support would increase the risk of overfitting (achieving overly optimistic predictive accuracy and hence resulting in failure to replicate the results elsewhere).<sup><xref rid="awac463-B42" ref-type="bibr">42</xref></sup></p></sec><sec id="awac463-s1.3.2"><title>Missing data</title><p>An <italic toggle="yes">a priori</italic> threshold was set to exclude from further analysis any variables with &#8805;30% of their values missing either within cases or within controls, based on previous literature.<sup><xref rid="awac463-B43" ref-type="bibr">43</xref></sup> We also excluded any variables with &gt;10% difference in the missing data burden between cases compared to controls.<sup><xref rid="awac463-B44" ref-type="bibr">44</xref></sup> These exclusions allowed us to prioritize creating a pragmatic RPM consisting of variables likely to be found complete in medical records, and that were uniformly represented between cases and controls. For variables with &lt;30% of their values missing, an overall summary of the missing data patterns was given and a logistic regression model for multiple imputation was used to replace the missing values. The missing values were imputed using fully conditional specification techniques based on the iterative Markov chain Monte Carlo method, with 20 imputed datasets gathered and imputed results pooled.<sup><xref rid="awac463-B45" ref-type="bibr">45</xref>,<xref rid="awac463-B46" ref-type="bibr">46</xref></sup> The missing data handling methods used were based on an assumption that data were missing at random. This was a plausible assumption given that a large number of clinically relevant variables were tested, meaning the probability of missingness would probably depend on only the observed data already captured within the dataset.<sup><xref rid="awac463-B47" ref-type="bibr">47</xref></sup></p></sec><sec id="awac463-s1.3.3"><title>Model development</title><p>Where possible, we reported both the original and imputed datasets for the models developed. Primary analysis was of the original data (complete case analysis), and the imputed data were used for sensitivity analysis.</p><p>Univariable analysis was performed using conditional logistic regression for included variables to provide an odds ratio (OR) and 95% CI.</p><p>Correlation was examined in a pairwise fashion between the variables, using contingency tables and chi-square tests with a two-sided 5% significance. Where correlation was significant (<italic toggle="yes">P</italic> &lt; 0.05 for both complete case and imputed data), the Lambda statistic was used to assess the strength of association, interpreted as 0.01&#8211;0.09 = weak, 0.10&#8211;0.29 = moderate, 0.30&#8211;0.99 = strong and 1.00 = perfect association.<sup><xref rid="awac463-B48" ref-type="bibr">48</xref></sup> Correlation was assessed for both cases and controls separately, with the highest Lambda statistic between both groups reported (<xref rid="awac463-T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="awac463-T2" orientation="portrait"><label>Table 2</label><caption><p>Correlation results for variable pairs</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Variable</th><th align="center" colspan="2" rowspan="1">Lambda correlation</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Seizure type</td><td rowspan="1" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">0.31</td><td rowspan="1" colspan="1">Strong association</td></tr><tr><td rowspan="1" colspan="1">Seen by neurologist</td><td rowspan="1" colspan="1">Number of ASMs</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">Moderate association</td></tr><tr><td rowspan="1" colspan="1">Seen by neurologist</td><td rowspan="1" colspan="1">CCI</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">Moderate association</td></tr><tr><td rowspan="1" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">CCI</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">Moderate association</td></tr><tr><td rowspan="1" colspan="1">Alcohol abuse</td><td rowspan="1" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">Moderate association</td></tr><tr><td rowspan="1" colspan="1">A&amp;E attendance or hospital admission</td><td rowspan="1" colspan="1">Mental health problems</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">Moderate association</td></tr><tr><td rowspan="1" colspan="1">SIMD quintile</td><td rowspan="1" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">Weak association</td></tr><tr><td rowspan="1" colspan="1">SIMD quintile</td><td rowspan="1" colspan="1">Seen by neurologist</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">Weak association</td></tr><tr><td rowspan="1" colspan="1">Alcohol abuse</td><td rowspan="1" colspan="1">Mental health problems</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">Weak association</td></tr></tbody></table></table-wrap><p>For model selection, two consultant epileptologists (S.E.D. and R.F.M.C.) independently made a clinically driven decision to select four variables for inclusion in the final RPM,<sup><xref rid="awac463-B42" ref-type="bibr">42</xref></sup> while blinded to the univariable results and considering variable correlations and missing data burdens (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>, section 2 for justification of each choice made). Any disagreements in variable selection were resolved by consensus. This variable selection approach was undertaken because it is often advised that variable selection should be focused more on clinical knowledge and previous literature than statistical selection methods alone.<sup><xref rid="awac463-B42" ref-type="bibr">42</xref>,<xref rid="awac463-B49" ref-type="bibr">49</xref></sup> The rationale is that it is better to select variables based on a wider body of clinical knowledge than to try to depend on statistical significance of results from a lesser quantity of information, particularly in a moderate-sized sample such as ours.<sup><xref rid="awac463-B50" ref-type="bibr">50</xref>,<xref rid="awac463-B51" ref-type="bibr">51</xref></sup> A data-driven, sample-based selection would be more sensitive to random variation in the data points due to sampling variability and more likely to generate false signals. Furthermore, there are several problems with the popular statistical selection methods themselves, including stepwise variable selection, backward elimination and forward selection, as summarized in detail elsewhere.<sup><xref rid="awac463-B50" ref-type="bibr">50</xref></sup></p><p>For multivariable analysis, multivariable conditional logistic regression was performed to provide ORs for the four variables selected for RPM, adjusted for one another, alongside 95% CIs. Any variables (or levels within variables) retaining significance within the univariable analysis were taken forward into the multivariable model, where they were compared against all remaining cases as a reference for nominal variables. For ordinal variables, any lower-ranking levels that were positive were combined with higher-ranking levels to create a positivity threshold. We assessed the positive variables within the multivariable model and assigned a weight (number of points) to each, based on the observed magnitudes of ORs in the complete case analysis, but also taking imputed data trends into account.<sup><xref rid="awac463-B52" ref-type="bibr">52</xref></sup> A sum of these points was then taken to give a total score, which we termed a Scottish Epilepsy Deaths Study Score (SEDS Score). An internal validation process was performed for each model (i.e. quantifying statistical performance of the model using the data on which the model was developed).<sup><xref rid="awac463-B15" ref-type="bibr">15</xref></sup> This was done by performing 1000 bootstrap analysis samples to provide more robust <italic toggle="yes">P</italic>-values, which were then checked for agreement against the original model&#8217;s <italic toggle="yes">P</italic>-values for each variable. Where there was poor agreement, the bootstrap result was prioritized.</p><p>We used Nagelkerke&#8217;s <italic toggle="yes">R</italic><sup>2</sup> to estimate what proportion of variance in the outcome was explained by the predictor variables in the model, and the Hosmer&#8211;Lemeshow goodness-of-fit test to determine whether the model adequately described these outcome data (where <italic toggle="yes">P</italic> &#8805; 0.05 indicates a good fit). The Hosmer&#8211;Lemeshow contingency table was used to assess model calibration by illustrating agreement between subgroups of predicted probabilities and their observed frequencies.<sup><xref rid="awac463-B15" ref-type="bibr">15</xref>,<xref rid="awac463-B53" ref-type="bibr">53</xref></sup> Discrimination describes how well the model differentiates between patients who experienced the outcome (deceased cases) and those who did not (living controls).<sup><xref rid="awac463-B15" ref-type="bibr">15</xref></sup> This would normally be measured using an area under the receiver operating characteristic curve.<sup><xref rid="awac463-B53" ref-type="bibr">53</xref></sup> However, receiver operating characteristic statistics can be misleading for binary or categorical predictors and, as such, they are cautioned against in this scenario.<sup><xref rid="awac463-B54" ref-type="bibr">54</xref>,<xref rid="awac463-B55" ref-type="bibr">55</xref></sup> Therefore, we approximated discrimination primarily through indicating the model&#8217;s ability to capture all of the deceased cases by estimating its sensitivity, and all of the living outcomes by estimating its specificity. Positive predictive value, negative predictive value and model accuracy [sensitivity &#215; prevalence + specificity &#215; (1 &#8722; prevalence)] were reported for reference only given that these estimates depend on prevalence of the outcome, which was fixed at 50% in this study because of the 1:1 matched case-control design: 95% CIs were included.</p></sec><sec id="awac463-s1.3.4"><title>Approvals</title><p>This study was approved by South East Scotland Research Ethics Committee 2 (15/SS/0165, IRAS 181131), and the Scottish Public Benefit and Privacy Panel for Health and Social Care.</p></sec></sec><sec sec-type="data-availability" id="awac463-s2"><title>Data availability</title><p>Approved researchers can access linked datasets via application to the electronic Data Research and Innovation Service (eDRIS) of the Scottish Information Services Division at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.isdscotland.org/Products-and-Services/eDRIS//" ext-link-type="uri">www.isdscotland.org/Products-and-Services/eDRIS//</ext-link>. Aggregate case-control data are available on reasonable request (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.muirmaxwellcentre.com/contact-us/" ext-link-type="uri">www.muirmaxwellcentre.com/contact-us/</ext-link>). For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.</p></sec></sec><sec sec-type="results" id="awac463-s3"><title>Results</title><sec id="awac463-s3.1"><title>Baseline characteristics of cases and controls</title><p>The study cohort comprised 224 deceased cases (114 male, 110 female) and 224 living controls (114 males, 110 female), spread across multiple NHS Health Board regions in Scotland (<xref rid="awac463-F1" ref-type="fig">Fig. 1</xref>).<sup><xref rid="awac463-B5" ref-type="bibr">5</xref>
,<xref rid="awac463-B17" ref-type="bibr">17</xref></sup> Mean age at death for cases was 48 years (&#177;17 SD, range 16&#8211;90). This was no different to the mean age at assessment of 48 years (&#177; 16 SD, range 19&#8211;87) for controls, demonstrating that the age-matching limits of &#177; 10 years did not result in any major differences in age between the cases and controls that were actually studied. A total of 124 control participants were recruited from SHARE Scotland,<sup><xref rid="awac463-B23" ref-type="bibr">23</xref></sup> with the remaining 100 recruited from NHS Lothian epilepsy clinics.</p><fig position="float" id="awac463-F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><p>
<bold>Study flow diagram.</bold> F25 = primary care diagnostic read codes for epilepsy; G40&#8211;41 = ICD-10 codes for epilepsy and status epilepticus; R56.8 = ICD-10 code for seizures; CHI = Scottish Community Health Index patient identification number.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="awac463f1.jpg"/></fig></sec><sec id="awac463-s3.2"><title>Missing data</title><p>Several predictor variables were excluded from further analysis owing to their missing data burden (<xref rid="awac463-T1" ref-type="table">Table 1</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>, section 2). The remaining variables were taken forward into multiple imputation and univariable analysis.</p></sec><sec id="awac463-s3.3"><title>Correlation</title><p>A strong association was seen only between the type of seizures (focal or general) and the risk factors for developing epilepsy (inherited/congenital or acquired) (<xref rid="awac463-T2" ref-type="table">Table 2</xref>. The remaining pairs demonstrated moderate or weak association, with the greatest association among these being between having been seen by a neurologist in the preceding year and the number of ASMs prescribed when last seen.</p></sec><sec id="awac463-s3.4"><title>Univariable analysis</title><p>The odds of epilepsy-related death occurring were significantly increased in those who lived in the two most deprived SIMD quintiles, those with a history of alcohol abuse in the preceding 2 years, those with generalized epilepsy, those who had experienced at least one accident and emergency (A&amp;E) attendance or hospital admission in the preceding year related to seizures or epilepsy, those with evidence of mental health problems in the preceding 2 years, those who had not been seen by a neurologist in the preceding year, those with a CCI of 2&#8211;3 and those with an inherited/congenital/genetic aetiology or risk factor acquired in early life (&lt;5 years of age) for developing epilepsy (<xref rid="awac463-T3" ref-type="table">Table 3</xref>). ORs and CIs for CCI 2&#8211;3 and &#8805;4 almost entirely overlapped, indicating a similar level of association beyond CCI &#8805;2 in this dataset. The odds of epilepsy-related death occurring were significantly reduced in those who had undergone previous epilepsy surgery in the complete case analysis. However, only a small number of cases and controls had had epilepsy surgery (&lt;10% of the sample, overall), and the difference associated with this variable was lost when imputed data were included. The number of ASMs taken when last seen were not significant individual predictors. Very few cases and controls (&lt;3% of the sample) were not on an ASM.</p><table-wrap position="float" id="awac463-T3" orientation="portrait"><label>Table 3</label><caption><p>Univariable results</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Predictor variable</th><th align="center" rowspan="2" colspan="1">Grouping</th><th align="center" colspan="2" rowspan="1">Study status</th><th align="center" rowspan="2" colspan="1">Total</th><th align="center" rowspan="2" colspan="1">Complete case data analysis<break/>OR (95% CI)</th><th align="center" rowspan="2" colspan="1">
<italic toggle="yes">P</italic>-value</th><th align="center" rowspan="2" colspan="1">Multiple imputation data<break/>OR (95% CI)</th><th align="center" rowspan="2" colspan="1">
<italic toggle="yes">P</italic>-value</th></tr><tr><th align="center" rowspan="1" colspan="1">Alive (control)</th><th align="center" rowspan="1" colspan="1">Deceased (case)</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">SIMD Quintile</td><td rowspan="1" colspan="1">Two least deprived</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Middle deprivation</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">1.8 (1.0&#8211;3.2)</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">1.8 (1.0&#8211;3.2)</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">
<bold>Two most deprived</bold>
</td><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1">131</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">
<bold>2.5</bold> (<bold>1.6&#8211;4.0)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>00</bold></td><td rowspan="1" colspan="1">
<bold>2.5</bold> (<bold>1.6&#8211;4.0)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>00</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">442</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Alcohol abuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">202</td><td rowspan="1" colspan="1">157</td><td rowspan="1" colspan="1">359</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Yes</bold>
</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">
<bold>4.4</bold> (<bold>2.2&#8211;9.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>3.7</bold> (<bold>1.8&#8211;7.9)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>001</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">215</td><td rowspan="1" colspan="1">199</td><td rowspan="1" colspan="1">414</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Seizure type</td><td rowspan="1" colspan="1">Focal epilepsy</td><td rowspan="1" colspan="1">153</td><td rowspan="1" colspan="1">119</td><td rowspan="1" colspan="1">272</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Generalized epilepsy</bold>
</td><td rowspan="1" colspan="1">71</td><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">176</td><td rowspan="1" colspan="1">
<bold>1.9</bold> (<bold>1.2&#8211;3.0)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>006</bold></td><td rowspan="1" colspan="1">
<bold>1.8</bold> (<bold>1.1&#8211;2.8)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>012</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">448</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">A&amp;E attendance or hospital admission</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">181</td><td rowspan="1" colspan="1">92</td><td rowspan="1" colspan="1">273</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Yes</bold>
</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">123</td><td rowspan="1" colspan="1">164</td><td rowspan="1" colspan="1">
<bold>5.1</bold> (<bold>3.2&#8211;8.3)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>5.1</bold> (<bold>3.2&#8211;8.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">215</td><td rowspan="1" colspan="1">437</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Mental health problems</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">101</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">181</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Yes</bold>
</td><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1">109</td><td rowspan="1" colspan="1">200</td><td rowspan="1" colspan="1">
<bold>1.6</bold> (<bold>1.0&#8211;2.6)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>034</bold></td><td rowspan="1" colspan="1">
<bold>1.6</bold> (<bold>1.1&#8211;2.4)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>027</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">192</td><td rowspan="1" colspan="1">189</td><td rowspan="1" colspan="1">381</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Epilepsy surgery</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">193</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">396</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Yes</bold>
</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">
<bold>0.2</bold> (<bold>0.1&#8211;0.5)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>001</bold></td><td rowspan="1" colspan="1">0.4 (0.1&#8211;1.4)</td><td rowspan="1" colspan="1">0.159</td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">209</td><td rowspan="1" colspan="1">431</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Seen by neurologist (entire dataset)</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">295</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>No</bold>
</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">106</td><td rowspan="1" colspan="1">148</td><td rowspan="1" colspan="1">
<bold>3.8</bold> (<bold>2.4&#8211;6.1)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>3.9</bold> (<bold>2.5&#8211;6.3)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">221</td><td rowspan="1" colspan="1">443</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Seen by neurologist (SHARE-only dataset)</td><td rowspan="1" colspan="1">
<bold>No</bold>
</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">87</td><td rowspan="1" colspan="1">
<bold>3.4</bold> (<bold>1.8&#8211;6.1)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">244</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">92</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Inherited/congenital/genetic/acquired early life</bold>
</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">114</td><td rowspan="1" colspan="1">
<bold>3.1</bold> (<bold>1.7&#8211;5.7)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>3.3</bold> (<bold>1.9&#8211;5.8)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr><tr><td rowspan="1" colspan="1">Acquired later life</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">131</td><td rowspan="1" colspan="1">1.7 (0.9&#8211;3.2)</td><td rowspan="1" colspan="1">0.088</td><td rowspan="1" colspan="1">
<bold>1.9</bold> (<bold>1.1&#8211;3.4)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>030</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">197</td><td rowspan="1" colspan="1">195</td><td rowspan="1" colspan="1">392</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">CCI score</td><td rowspan="1" colspan="1">0&#8211;1</td><td rowspan="1" colspan="1">143</td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">270</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>2&#8211;3</bold>
</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">
<bold>2.5</bold> (<bold>1.2&#8211; 5.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>010</bold></td><td rowspan="1" colspan="1">
<bold>3.3</bold> (<bold>1.7&#8211;6.6)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr><tr><td rowspan="1" colspan="1">&#8805;4</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">2.0 (0.7&#8211;5.2)</td><td rowspan="1" colspan="1">0.200</td><td rowspan="1" colspan="1">
<bold>3.2</bold> (<bold>1.2&#8211;8.3)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>018</bold></td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">195</td><td rowspan="1" colspan="1">215</td><td rowspan="1" colspan="1">410</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">Number of AEDs</td><td rowspan="1" colspan="1">Not on an ASM</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">1 ASM</td><td rowspan="1" colspan="1">101</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">197</td><td rowspan="1" colspan="1">0.4 (0.1&#8211;1.3)</td><td rowspan="1" colspan="1">0.127</td><td rowspan="1" colspan="1">0.3 (0.1&#8211;1.3)</td><td rowspan="1" colspan="1">0.336</td></tr><tr><td rowspan="1" colspan="1">2 ASMs</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">142</td><td rowspan="1" colspan="1">0.4 (0.1&#8211;1.6)</td><td rowspan="1" colspan="1">0.201</td><td rowspan="1" colspan="1">0.4 (0.1&#8211;1.5)</td><td rowspan="1" colspan="1">0.397</td></tr><tr><td rowspan="1" colspan="1">&#8805;3 ASMs</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">0.3 (0.1&#8211;1.2)</td><td rowspan="1" colspan="1">0.098</td><td rowspan="1" colspan="1">0.3 (0.1&#8211;1.2)</td><td rowspan="1" colspan="1">0.289</td></tr><tr><td colspan="2" rowspan="1">Total</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">223</td><td rowspan="1" colspan="1">447</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="awac463-tblfn6"><p>Bold font within the table body corresponds to statistically significant results.</p></fn></table-wrap-foot></table-wrap><p>In an exploratory <italic toggle="yes">post hoc</italic> analysis, the odds of epilepsy-related death occurring remained significantly increased in those who had not been seen by a neurologist in the preceding year even with analysis restricted to using only the SHARE control participants. This indicates that this variable was significant even when excluding the sample of control participants recruited directly from epilepsy clinics.</p></sec><sec id="awac463-s3.5"><title>Multivariable analysis</title><p>The four variables ultimately selected for multivariable analysis are listed here (see <xref rid="awac463-T1" ref-type="table">Table 1</xref> for expanded definitions of each variable): (i) SIMD quintile; (ii) A&amp;E attendance or hospital admission for epilepsy/seizures; (iii) aetiology and risk factors for developing epilepsy; and (iv) CCI.</p><p>
<xref rid="awac463-T4" ref-type="table">Table 4</xref> summarizes results of the multivariable model derived from these four variables. The SEDS Score will be calculated by taking a sum of these factors, when present, weighted as<sup><xref rid="awac463-B52" ref-type="bibr">52</xref></sup>:</p><list list-type="simple"><list-item><label>(i)</label><p>One point for a CCI of &#8805;2: A CCI score &#8805;2 was given the lowest weighting of 1 as it had an OR of only 1.6 in complete case analysis (which was not significant), but an OR of 2.6 in multiple imputation analysis (which was significant). Our clinical interpretation of this, supported by prior literature,<sup><xref rid="awac463-B33" ref-type="bibr">33&#8211;35</xref></sup> would suggest higher CCI scores would normally be associated with increased mortality; suggesting some of the missing data within our CCI variable could have contributed to the lower complete case result. However, we applied a cautious weighting of only 1 as we did not wish to inflate the weight for this variable given the complete case result, which was the basis for primary analysis.</p></list-item><list-item><label>(ii)</label><p>Two points for having inherited/congenital/genetic aetiology or early-life acquired risk factors for developing epilepsy: assigned this weight because the complete case OR for this variable was higher than for CCI &#8805;2, was in a similar range to OR for the two most deprived SIMD quintiles and was lower than OR for A&amp;E attendance or hospital admission.</p></list-item><list-item><label>(iii)</label><p>Two points for living in the two most deprived SIMD quintiles: assigned this weight because complete case OR for this variable was similar to OR for inherited/congenital/genetic aetiology or early-life acquired risk factors for developing epilepsy.</p></list-item><list-item><label>(iv)</label><p>Three points for at least one seizure- or epilepsy-related A&amp;E attendance and/or hospital admission in the preceding year: assigned this weight because this variable had the highest complete case OR.</p></list-item></list><table-wrap position="float" id="awac463-T4" orientation="portrait"><label>Table 4</label><caption><p>Multivariable modelling</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Predictor variable</th><th align="center" rowspan="1" colspan="1">Grouping</th><th align="center" rowspan="1" colspan="1">Complete case data analysis<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">Bootstrap <italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">Multiple imputation data<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">SEDS Score weighting</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">SIMD Quintile</td><td rowspan="1" colspan="1">Two least deprived and two middle deprived</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Two most deprived</bold>
</td><td rowspan="1" colspan="1">
<bold>2.2 (1.2&#8211;3.8)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>009</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1">
<bold>2.2 (1.3&#8211;3.8)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>003</bold></td><td rowspan="1" colspan="1">
<bold>2</bold>
</td></tr><tr><td rowspan="2" colspan="1">A&amp;E attendance or hospital admission</td><td rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Yes</bold>
</td><td rowspan="1" colspan="1">
<bold>4.2 (2.3&#8211;7.7)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>001</bold></td><td rowspan="1" colspan="1">
<bold>4.7 (2.7&#8211;8.0)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>3</bold>
</td></tr><tr><td rowspan="2" colspan="1">Aetiology and risk factors for developing epilepsy</td><td rowspan="1" colspan="1">No risk factors and acquired later life risk factors</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Inherited/congenital/genetic/acquired early life</bold>
</td><td rowspan="1" colspan="1">
<bold>2.8 (1.4&#8211;5.6)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>003</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1">
<bold>3.5 (1.8&#8211;6.5)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>2</bold>
</td></tr><tr><td rowspan="2" colspan="1">CCI score</td><td rowspan="1" colspan="1">0&#8211;1</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8805;2</td><td rowspan="1" colspan="1">1.6 (0.6&#8211;4.3)</td><td rowspan="1" colspan="1">0.389</td><td rowspan="1" colspan="1">0.413</td><td rowspan="1" colspan="1">
<bold>2.6 (1.1&#8211;6.1)</bold>
</td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>034</bold></td><td rowspan="1" colspan="1">
<bold>1</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="awac463-tblfn7"><p>Bold font within the table body corresponds to statistically significant results.</p></fn></table-wrap-foot></table-wrap><p>Therefore, each individual could have a SEDS Score of 0&#8211;8.</p><p>Model diagnostics showed evidence of internal validity for this multivariable model, with the <italic toggle="yes">P</italic>-values from 1000 bootstrap samples matching the significance patterns of the complete case analysis. The model was a good fit for the data (<italic toggle="yes">P</italic> &gt; 0.05 for the Hosmer&#8211;Lemeshow goodness-of-fit test both using complete case and imputed data) and 30% of the variance in the outcome was explained by the predictor variables included in this model (<italic toggle="yes">R</italic><sup>2</sup> = 0.303). The model demonstrated good calibration, with the predicted estimates mirroring the actual estimates closely throughout the Hosmer&#8211;Lemeshow contingency table (<xref rid="awac463-T5" ref-type="table">Table 5</xref>). In terms of discrimination, the model demonstrated a sensitivity of 72% (95% CI 65&#8211;78%) and specificity of 72% (95% CI 65&#8211;79%) in the complete case analysis, indicating that most cases and controls were identified. There was little difference in these discrimination figures when imputed values were included. Positive predictive value, negative predictive value and model accuracy were 74% (95% CI 69&#8211;79%), 70% (95% CI 64&#8211;75%) and 72% (95% CI 67&#8211;77%), respectively.</p><table-wrap position="float" id="awac463-T5" orientation="portrait"><label>Table 5</label><caption><p>Contingency table for the Hosmer and Lemeshow test</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="center" colspan="4" rowspan="1">Multivariable model</th><th align="center" colspan="4" rowspan="1">SEDS Score model</th></tr><tr><th align="left" colspan="2" rowspan="1">Study status = alive (control)</th><th align="center" colspan="2" rowspan="1">Study status = deceased (case)</th><th align="center" colspan="2" rowspan="1">Study status = alive (control)</th><th align="center" colspan="2" rowspan="1">Study status = deceased (case)</th></tr><tr><th align="left" rowspan="1" colspan="1">Observed</th><th align="center" rowspan="1" colspan="1">Predicted</th><th align="center" rowspan="1" colspan="1">Observed</th><th align="center" rowspan="1" colspan="1">Predicted</th><th align="center" rowspan="1" colspan="1">Observed</th><th align="center" rowspan="1" colspan="1">Predicted</th><th align="center" rowspan="1" colspan="1">Observed</th><th align="center" rowspan="1" colspan="1">Predicted</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">12</td></tr><tr><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">10</td></tr><tr><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">102</td><td rowspan="1" colspan="1">102</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">73</td></tr><tr><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">81</td></tr><tr><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">48</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">&lt;5</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr></tbody></table></table-wrap><p>The SEDS Scores were analysed in a multivariable model (SEDS Score model), using a score of 0 points as the reference category. This was compared to SEDS Scores in groups of 1, 2&#8211;3, 4&#8211;5 and 6&#8211;8. The results of this model are summarized in <xref rid="awac463-T6" ref-type="table">Table 6</xref>. The odds of epilepsy-related death occurring were not significantly increased in those with a SEDS Score of 1. The odds were then significantly increased in the remaining SEDS Score groups. The suggestion of a dose-response in increasing odds was seen, with OR increasing from 2.8 to 14.4, then 24.0 for SEDS Scores of 2&#8211;3, 4&#8211;5 and 6&#8211;8, respectively. However, there were also increasingly fewer cases and controls as SEDS Score increased, which acted to widen the CIs and thereby reduce confidence about the precise magnitude of odds as they increased. There was little difference between the complete case and imputed data analysis for SEDS Score modelling.</p><table-wrap position="float" id="awac463-T6" orientation="portrait"><label>Table 6</label><caption><p>SEDS Score model results</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">SEDS Score</th><th align="center" rowspan="1" colspan="1">Alive (control)</th><th align="center" rowspan="1" colspan="1">Deceased (case)</th><th align="center" rowspan="1" colspan="1">Complete case data analysis<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">Bootstrap <italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">Multiple imputation data<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">1.6 (0.5&#8211;4.8)</td><td rowspan="1" colspan="1">0.443</td><td rowspan="1" colspan="1">0.456</td><td rowspan="1" colspan="1">1.7 (0.5&#8211;6.2)</td><td rowspan="1" colspan="1">0.412</td></tr><tr><td rowspan="1" colspan="1">
<bold>2&#8211;3</bold>
</td><td rowspan="1" colspan="1">102</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">
<bold>2.8</bold> (<bold>1.3&#8211;6.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>009</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>009</bold></td><td rowspan="1" colspan="1">
<bold>3.3</bold> (<bold>1.3&#8211;8.5)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>012</bold></td></tr><tr><td rowspan="1" colspan="1">
<bold>4&#8211;5</bold>
</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">
<bold>14.4</bold> (<bold>5.9&#8211;35.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>001</bold></td><td rowspan="1" colspan="1">
<bold>14.7</bold> (<bold>5.4&#8211;39.9)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr><tr><td rowspan="1" colspan="1">
<bold>6&#8211;8</bold>
</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">
<bold>24.0</bold> (<bold>8.1&#8211;71.2)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>001</bold></td><td rowspan="1" colspan="1">
<bold>29.5</bold> (<bold>9.1&#8211;96.3)</bold></td><td rowspan="1" colspan="1">
<bold>0</bold>.<bold>000</bold></td></tr></tbody></table><table-wrap-foot><fn id="awac463-tblfn8"><p>Bold font within the table body corresponds to statistically significant results.</p></fn></table-wrap-foot></table-wrap><p>Model diagnostics showed evidence of internal model validity for the SEDS Score, with the <italic toggle="yes">P</italic>-values from 1000 bootstrap samples matching the significance patterns of the complete case analysis. The model was also a good fit for the data (<italic toggle="yes">P</italic> &gt; 0.05 for the Hosmer&#8211;Lemeshow goodness-of-fit test both using complete case and imputed data): 28% of the variance in the outcome was explained by the predictor variables included in this model (<italic toggle="yes">R</italic><sup>2</sup> = 0.283). The model also demonstrated good calibration, with the predicted estimates mirroring the actual estimates closely throughout the Hosmer&#8211;Lemeshow contingency table (<xref rid="awac463-T5" ref-type="table">Table 5</xref>). In terms of discrimination, the model demonstrated a sensitivity of 58% (95% CI 51&#8211;64%) and specificity of 84% (95% CI 78&#8211;88%) using complete case data. There was little difference in these discrimination figures when imputed values were included. Positive predictive value, negative predictive value and model accuracy were 78% (95% CI 72&#8211;83%), 66% (95% CI 63&#8211;70%) and 71% (95% 66&#8211;75%), respectively.</p></sec></sec><sec sec-type="discussion" id="awac463-s4"><title>Discussion</title><sec id="awac463-s4.1"><title>Summary of findings</title><p>In the first reported case-control study investigating epilepsy-related death in Scotland, data from the medical records of 224 deceased cases and living controls from multiple regional centres were analysed to identify several potential risk factors for epilepsy-related death and to develop a pragmatic RPM for identifying those at the highest risk.</p><p>In terms of risk factors, univariable analysis revealed that eight variables were significantly associated with increased risk of epilepsy-related death. These were having a recent A&amp;E attendance or hospital admission for seizures or epilepsy, a recent history of alcohol abuse, absent recent neurology review, the presence of inherited/congenital/genetic aetiology or early-life acquired risk factors for developing epilepsy, living in the two most deprived Scottish quintile areas, generalized epilepsy, a recent history of mental health problems and having a raised comorbidity burden (CCI &#8805;2). ORs ranged between 1.6 and 5.1 between these variables. Multivariable modelling was undertaken for the positive factors within variables CCI (&#8805;2 assigned 1 point), SIMD quintile (two most deprived assigned 2 points); aetiology or risk factors for developing epilepsy (inherited/congenital/genetic aetiology or early-life acquired risk factors assigned 2 points) and A&amp;E attendance or hospital admission for epilepsy/seizures (assigned 3 points). Modelling of the composite SEDS Scores derived from these points revealed three levels of risk for epilepsy-related death occurring: low risk in those with a SEDS Score of 1 (ORs 1.6&#8211;1.7), moderate risk for a SEDS Score of 2&#8211;3 (ORs 2.8&#8211;3.3) and high risk for a SEDS Score of &#8805;4 (ORs 14.4&#8211;14.7 for SEDS Scores 4&#8211;5 and 24.0&#8211;29.5 for SEDS Scores 6&#8211;8). Wide CIs were noted surrounding the high-risk groups, owing to increasingly fewer events as factors were combined. This serves to justify proceeding to a larger study in a different country to externally validate the model and narrow CIs further in the process.<sup><xref rid="awac463-B56" ref-type="bibr">56</xref></sup> The <xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>, section 3 illustrates the potential avenue to clinical implementation of the SEDS Score as an example risk scoring card for frontline clinicians to use (also available as an interactive prototype at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://seds-tool.github.io/seds/" ext-link-type="uri">seds-tool.github.io/seds</ext-link>).</p></sec><sec id="awac463-s4.2"><title>Interpretation</title><p>Aside from a history of inherited/congenital/genetic aetiology or early-life acquired risk factors and risk factors for developing epilepsy, the remaining three predictors used to generate the SEDS Score were potentially modifiable and serve as a target for future risk prevention strategies clinically or from a wider epidemiological perspective. Seizures are the most common neurological cause of unscheduled hospital admission in the UK.<sup><xref rid="awac463-B57" ref-type="bibr">57</xref></sup> While such admissions are a sign of poorer epilepsy control, they are often clinically unnecessary and typically lead to little benefit for epilepsy management.<sup><xref rid="awac463-B58" ref-type="bibr">58</xref>,<xref rid="awac463-B59" ref-type="bibr">59</xref></sup> As such, there are several studies proposing methods to reduce seizure-related admissions in people with epilepsy.<sup><xref rid="awac463-B59" ref-type="bibr">59&#8211;61</xref></sup> This may be achieved through, for example, intensifying scheduled specialist and community resources for people with epilepsy, or developing alternative care pathways.<sup><xref rid="awac463-B61" ref-type="bibr">61</xref>,<xref rid="awac463-B62" ref-type="bibr">62</xref></sup> Our study findings support this need as we show that seizure-related hospital admissions were the strongest predictor for subsequent epilepsy-related death. SIMD is modifiable from a population perspective, including from government incentives targeted towards high-risk groups.<sup><xref rid="awac463-B28" ref-type="bibr">28</xref></sup> Comorbidities must managed using approaches such as multidisciplinary team clinics to help reduce mortality.<sup><xref rid="awac463-B63" ref-type="bibr">63</xref></sup></p><p>While it is well established in literature that alcohol abuse, congenital or developmental epilepsies, social deprivation, generalized epilepsy and mental health problems are risk factors for all-cause mortality in people with epilepsy,<sup><xref rid="awac463-B3" ref-type="bibr">3</xref>,<xref rid="awac463-B7" ref-type="bibr">7</xref>,<xref rid="awac463-B64" ref-type="bibr">64</xref></sup> we show that they can be further streamlined into predicting epilepsy-related mortality specifically. Furthermore, we test the role of recent A&amp;E attendance or hospital admission for seizures and epilepsy on predicting epilepsy-related mortality, and the role of absent neurology review within a year on this outcome. There is little study of these two variables in epilepsy mortality literature.<sup><xref rid="awac463-B3" ref-type="bibr">3</xref></sup> Our data suggest the odds of epilepsy-related death occurring may be up to five times increased in those attending A&amp;E or admitted to hospital for seizures/epilepsy within a year, and up to three times increased in those not reviewed by a neurologist within a year. The SUDEP and Seizure Safety Checklist is a free evidence-based tool supporting clinicians in discussing risk with people with epilepsy, with over 1000 clinician subscribers in the UK currently.<sup><xref rid="awac463-B11" ref-type="bibr">11</xref></sup> It lists risk factors linked to epilepsy mortality including (but not restricted to) SUDEP. However, it was not developed using regression modelling of the proposed risk factors against one another, but rather as expert consensus on risk factors identified in literature.<sup><xref rid="awac463-B11" ref-type="bibr">11</xref></sup> These risk factors include, for example, active seizures, generalized tonic-clonic seizures, status epilepticus, nocturnal seizures, poor medicine adherence, alcohol or substance misuse and depression.<sup><xref rid="awac463-B11" ref-type="bibr">11</xref></sup> Following on from the findings of our study, it may be reasonable to consider including A&amp;E attendance or hospital admission within the preceding year for seizures/epilepsy, or including absent neurology review within a year in future iterations of the SUDEP and Seizure Safety Checklist.</p><p>RPMs should be both internally and externally validated before being adopted into clinical practice.<sup><xref rid="awac463-B15" ref-type="bibr">15</xref>,<xref rid="awac463-B56" ref-type="bibr">56</xref></sup> The preferred approach for internal validation is bootstrapping, which we have undertaken.<sup><xref rid="awac463-B15" ref-type="bibr">15</xref>,<xref rid="awac463-B56" ref-type="bibr">56</xref></sup> The preferred approach for external validation uses independent data from a different location than the development data to reassesses model performance.<sup><xref rid="awac463-B56" ref-type="bibr">56</xref></sup> This is the logical next phase of research for the SEDS Score, and could be undertaken using the national Secure Anonymized Information Linkage databank in Wales, for example.<sup><xref rid="awac463-B65" ref-type="bibr">65</xref>,<xref rid="awac463-B66" ref-type="bibr">66</xref></sup> Prognostic models can also be assessed for their impact in a clinical setting.<sup><xref rid="awac463-B56" ref-type="bibr">56</xref></sup> For example, mortality outcomes could be compared between patients managed by clinicians with and without access to the SEDS Score for triaging.<sup><xref rid="awac463-B56" ref-type="bibr">56</xref></sup> Such an approach was taken in the STarTBack trial for back pain and the results showed a significantly larger reduction in disability as well as cost savings in the group receiving prediction-model-based care compared with controls.<sup><xref rid="awac463-B56" ref-type="bibr">56</xref></sup></p><p>Our study develops an RPM using standard observational methods for this purpose.<sup><xref rid="awac463-B15" ref-type="bibr">15</xref>,<xref rid="awac463-B56" ref-type="bibr">56</xref></sup> It does not test interventions to alter the SEDS Score variables or overall score, nor the effect this would have on mortality. This would require a clinical trial. Therefore, we are unable to make recommendations to clinicians about how to manage their patients effectively once a high SEDS Score is identified. Such management would need to be individualized on the basis of patient circumstances, local policy and available treatments. However, by identifying the high-risk individuals, our RPM would support clinicians in triaging which patients need to be prioritized. For example, in a non-specialist setting, where such patients often first present,<sup><xref rid="awac463-B57" ref-type="bibr">57</xref>,<xref rid="awac463-B58" ref-type="bibr">58</xref></sup> a high SEDS Score could prompt re-discussion about seizure safety, signposting online resources for support (such as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.epilepsy.org.uk/info" ext-link-type="uri">www.epilepsy.org.uk/info</ext-link>) and rapid-access epilepsy clinic referral (rather than reserving such clinics for first-fit patients alone). The potential impact of such approaches is well recognized. For example, the asthma deaths review demonstrated that many deaths were likely to be preventable simply through better proactive clinical management, such as arranging for patients to be seen promptly after a hospital admission and through following clinical guidelines.<sup><xref rid="awac463-B67" ref-type="bibr">67</xref></sup> In a specialist setting, a high SEDS Score could prompt referral for epilepsy surgery earlier than would have otherwise been considered, discussion in a multidisciplinary team meeting, further medication reviews or implementation of seizure alarms and nocturnal supervision.</p><p>Our previous study corroborated a heavy burden of seizure-related A&amp;E attendances and hospital admissions in the period leading up to epilepsy-related death, with a substantial number of these patients lacking any recent neurology review or follow-up.<sup><xref rid="awac463-B5" ref-type="bibr">5</xref></sup> Such A&amp;E attendances and hospital admissions therefore represent missed opportunities for creating effective pathways to specialist care, a problem also highlighted in England.<sup><xref rid="awac463-B58" ref-type="bibr">58</xref></sup> As such, it would be important for the SEDS Score to be available to non-specialist doctors including general practitioners, general physicians and emergency care doctors, and for it to be designed in such a way that these non-specialists could use the tool. This includes basing it on variables likely to have little missing data in these non-specialist medical records. Support from local and national charities and organizations would help with disseminating the model to non-specialist areas, as is being done by SUDEP Action for the SUDEP and Seizure Safety Checklist.<sup><xref rid="awac463-B11" ref-type="bibr">11</xref></sup> We would also apply to have the SEDS Score included in free online clinical scoring tool databases, such as MDCalc (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdcalc.com" ext-link-type="uri">www.mdcalc.com</ext-link>), meaning it would be easily accessible globally.<sup><xref rid="awac463-B36" ref-type="bibr">36</xref></sup></p><p>The methods used in our study can be translated to any country with unique patient identifiers and linked administrative data or electronic health records. For example, all patients using NHS services in England benefit from a unique patient identifier (NHS number). A study was recently published evaluating a nationwide cohort of &gt;54 million people in England using NHS number-linked electronic health records and administrative data.<sup><xref rid="awac463-B68" ref-type="bibr">68</xref></sup> Studies from outside of the UK have used a similar approach, including in the USA,<sup><xref rid="awac463-B69" ref-type="bibr">69</xref></sup> Canada,<sup><xref rid="awac463-B70" ref-type="bibr">70</xref></sup> Sweden<sup><xref rid="awac463-B71" ref-type="bibr">71</xref></sup> and South Africa.<sup><xref rid="awac463-B72" ref-type="bibr">72</xref></sup> Our methodology is focused on developing a generalizable RPM, selecting variables that are clinically and statistically appropriate to include, with little overall missing data. Consequently, the model identifies four risk factors that should be readily available within patient medical records and could even be obtained from administrative data, facilitating clinical implementation or research in other regions in future. Each variable has been successfully studied in other global regions using electronic health records or administrative data.<sup><xref rid="awac463-B3" ref-type="bibr">3</xref>,<xref rid="awac463-B57" ref-type="bibr">57</xref>,<xref rid="awac463-B73" ref-type="bibr">73&#8211;76</xref></sup></p></sec><sec id="awac463-s4.3"><title>Study limitations</title><p>A limited sample size allowed development of only a four-variable RPM. This is, however, a similar model size to the three-item SUDEP-3 inventory&#8212;an RPM for SUDEP that was developed from a seven-item inventory (SUDEP-7).<sup><xref rid="awac463-B9" ref-type="bibr">9</xref>,<xref rid="awac463-B10" ref-type="bibr">10</xref>,<xref rid="awac463-B12" ref-type="bibr">12</xref></sup> While a smaller sample allowed us to investigate each medical record in greater detail, it meant we were unable match cases and controls by centre, instead pooling them all into one Scottish centre. However, both the cases and controls were mainly recruited from Scotland&#8217;s Central Belt region (Glasgow, Ayrshire, Falkirk, Edinburgh, Lothian and Fife; <xref rid="awac463-F1" ref-type="fig">Fig. 1</xref>).</p><p>Controls were drawn from those signing up to SHARE and those attending epilepsy clinics, yet no such selection process applied to cases. This may have created a selection bias, especially towards controls being generally healthier than cases. This is unlikely to have influenced the conclusions we drew from SEDS Scoring as the OR figures for this were markedly high, and would therefore be unlikely to have been entirely attributable to differences in baseline characteristics of the groups. Furthermore, SHARE provided evidence their study population is representative of the general Scottish population in terms SIMD and ethnicity (<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>, section 4) with percentage difference between the two being no more than 2% in each SIMD decile: 4% and 7% of the general population and SHARE population, respectively, are from ethnic minority backgrounds.</p><p>Although our study attempted to extract data on several other potentially modifiable risk factors for epilepsy-related death including seizure frequency, timing, seizure alarm use and a history of status epilepticus, large amounts of missing data in the medical records precluded analysis of these. We were strict to exclude from further analysis any variables with &#8805;30% missing data because including variables with large amounts of missing data would not only substantially reduce the model&#8217;s predictive power,<sup><xref rid="awac463-B43" ref-type="bibr">43</xref></sup> but also it would curtail its clinical utility. This is because end users might also struggle to find these variables within their medical records. The resultant predictive tool should, therefore, be more widely applicable in a range of clinical environments. Not all variables within the model would need to be modifiable for the model to be effective at identifying high-risk groups and allowing triage to effective management that might be independent of the specific risk factors identified. For example, within the widely used A&#8212;Age, B&#8212;Blood pressure, C&#8212;Clinical transient ischaemic attack features, D&#8212;Duration of symptoms and D&#8212;Diabetes (ABCD2) score to identify those at high risk of stroke following transient ischaemic attack,<sup><xref rid="awac463-B77" ref-type="bibr">77</xref></sup> only diabetes and blood pressure are modifiable. However, the tool is effective at helping prevent stroke because it identifies those at high risk effectively and therefore allows earlier implementation of stroke prevention strategies beyond simply controlling blood pressure and diabetes, including lipid profiling, cardiac monitoring, carotid imaging and considering dual antiplatelets.<sup><xref rid="awac463-B78" ref-type="bibr">78</xref></sup></p><p>Our model was a good fit for the data statistically, as demonstrated by a <italic toggle="yes">P</italic>-value &gt;0.05 on the Hosmer&#8211;Lemeshow goodness-of-fit test. The absolute figures for discrimination through sensitivity and specificity estimates were moderate, &#8764;70%. This highlights some of the complexities of regression model interpretation, which measures predictive ability in several different ways. Discrimination is related to correctly separating individuals with and without disease. Therefore, it is more important in diagnostic accuracy studies, unlike ours. Calibration measures the agreement between observed and predicted risk, and is therefore more important in prognostic studies such as ours.<sup><xref rid="awac463-B79" ref-type="bibr">79</xref></sup> Calibration is demonstrated highly in our model by the predicted estimates mirroring the actual estimates closely throughout the Hosmer&#8211;Lemeshow contingency table (<xref rid="awac463-T5" ref-type="table">Table 5</xref>). This is reassuring for the clinical conclusions drawn from this model.</p><p>Finally, the study was designed to identify those at increased risk of epilepsy-related deaths as a group, but made no attempt to risk stratify according to the type of epilepsy-related death specifically, e.g. SUDEP, drowning, accidents or suicide. A future study could attempt to further stratify by type of epilepsy-related death following on from our demonstration of increased risks for the overall group.</p></sec></sec><sec id="awac463-s5"><title>Conclusion</title><p>We propose the SEDS Score as a potential tool for identifying adults at increased risk of epilepsy-related death based on their recent attendance history to hospital for seizures or epilepsy, area of deprivation, epilepsy aetiology profile and their serious comorbidity burden. This 4-point score needs external validation in another healthcare system.<sup><xref rid="awac463-B15" ref-type="bibr">15</xref>,<xref rid="awac463-B56" ref-type="bibr">56</xref></sup> The SEDS Score has the potential to be applied clinically to help streamline frontline care for people with epilepsy and to inform clinical discussions with patients about risk. We describe additional risk factors to consider as part of the overall analysis of epilepsy-related mortality risk in people with epilepsy, including recent review by a neurologist, alcohol abuse and mental health problems. There is the potential for a larger study to try to incorporate these into future iterations of the SEDS Score and for them to be included in other tools such as in the SUDEP and Seizure Safety Checklist.<sup><xref rid="awac463-B11" ref-type="bibr">11</xref></sup> The missing data patterns in our study for several other potentially modifiable risk factors for epilepsy-related indicate the need for better clinical documentation within medical records, perhaps with use of seizure history collection proformas in non-specialist areas. There is also a need for more granular administrative healthcare data sources to allow such variables to be studied at scale.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data" orientation="portrait"><label>awac463_Supplementary_Data</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="awac463_supplementary_data.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>We are grateful for the statistical support provided for this work by Jacqueline Stephen and Christopher Weir. We also thank Saif Razvi (NHS Ayrshire and Arran), Myles Connor (NHS Borders), Ondrej Dolezal (NHS Dumfries and Galloway), Russell Hewett (NHS Greater Glasgow and Clyde), Linda Gerrie and Graham Mackay (NHS Grampian), Martin Zeidler (NHS Fife), Katy Murray (NHS Forth Valley), Kate Taylor (NHS Highland), John Paul Leach (NHS Lanarkshire), Kathleen White and Ian Morrison (NHS Tayside) for arranging access to medical records in the respective areas. We would like to acknowledge the support of the eDRIS Team (electronic Data Research and Innovation Service, National Services Scotland) for their involvement in obtaining approvals, provisioning and linking data and the use of the secure analytical platform within the National Safe Haven. Recruitment to this study was facilitated by SHARE&#8212;the Scottish Health Research Register and Biobank. SHARE is supported by NHS Research Scotland, Universities of Scotland and the Chief Scientists Office. We thank the SHARE participants. We also thank the Lothian epilepsy nurses, particularly Yvonne Leavy, for helping with recruiting clinic control participants. We are also grateful to Siddharthan Chandran, Catherine Sudlow and William Whiteley for strategic support and advice on the project. We are grateful to Jane Andrews and Karen Chalmers for administerial support in relation to this work.</p></ack><sec id="awac463-s6"><title>Funding</title><p>This work was charitably supported by Epilepsy Research UK (R44007) and the Juliet Bergqvist Memorial Fund. The funding sources played no role in the study design, data collection, data analysis, interpretation of results or the preparation and decision to submit the article for publication. The researchers remain independent from the funders.</p></sec><sec sec-type="COI-statement" id="awac463-s7"><title>Competing interests</title><p>The authors report no competing interests.</p></sec><sec id="awac463-s8"><title>Supplementary material</title><p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Brain</italic> online.</p></sec><ref-list id="ref1"><title>References</title><ref id="awac463-B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Trevick</surname><given-names>S</given-names></string-name></person-group>. <article-title>The epidemiology of global epilepsy</article-title>. <source>Neurol Clin</source>. <year>2016</year>;<volume>34</volume>:<fpage>837</fpage>&#8211;<lpage>847</lpage>.<pub-id pub-id-type="pmid">27719996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ncl.2016.06.015</pub-id></mixed-citation></ref><ref id="awac463-B2"><label>2</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>Joint Epilepsy Council of the UK and Ireland</collab></person-group>. <comment>Epilepsy prevalence, incidence and other statistics. 2011.</comment></mixed-citation></ref><ref id="awac463-B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mbizvo</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Bennett</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>RFM</given-names></string-name></person-group>. <article-title>Epilepsy-related and other causes of mortality in people with epilepsy: A systematic review of systematic reviews</article-title>. <source>Epilepsy Res</source>. <year>2019</year>;<volume>157</volume>:<comment>106192</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eplepsyres.2019.106192</pub-id><pub-id pub-id-type="pmid">31526975</pub-id></mixed-citation></ref><ref id="awac463-B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Spruill</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Thurman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name></person-group>. <article-title>Recognizing and preventing epilepsy-related mortality: A call for action</article-title>. <source>Neurology</source>. <year>2016</year>;<volume>86</volume>:<fpage>779</fpage>&#8211;<lpage>786</lpage>.<pub-id pub-id-type="pmid">26674330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000002253</pub-id><pub-id pub-id-type="pmcid">PMC4763802</pub-id></mixed-citation></ref><ref id="awac463-B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mbizvo</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Schnier</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>RFM</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>SE</given-names></string-name></person-group>. <article-title>A national study of epilepsy-related deaths in Scotland: Trends, mechanisms, and avoidable deaths</article-title>. <source>Epilepsia</source>. <year>2021</year>;<volume>62</volume>:<fpage>2667</fpage>&#8211;<lpage>2684</lpage>.<pub-id pub-id-type="pmid">34537957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.17065</pub-id></mixed-citation></ref><ref id="awac463-B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Neligan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sander</surname><given-names>JW</given-names></string-name></person-group>. <article-title>Premature mortality in epilepsy: Is it preventable?</article-title><source>Expert Rev Neurother</source>. <year>2011</year>;<volume>11</volume>:<fpage>767</fpage>&#8211;<lpage>770</lpage>.<pub-id pub-id-type="pmid">21651322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1586/ern.11.72</pub-id></mixed-citation></ref><ref id="awac463-B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thurman</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Logroscino</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Beghi</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group><article-title>The burden of premature mortality of epilepsy in high-income countries: A systematic review from the mortality task force of the international league against epilepsy</article-title>. <source>Epilepsia</source>. <year>2017</year>;<volume>58</volume>:<fpage>17</fpage>&#8211;<lpage>26</lpage>.<pub-id pub-id-type="pmid">27888514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.13604</pub-id><pub-id pub-id-type="pmcid">PMC7004822</pub-id></mixed-citation></ref><ref id="awac463-B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sander</surname><given-names>B</given-names></string-name></person-group>. <article-title>Reducing mortality: An important aim of epilepsy management</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2004</year>;<volume>75</volume>:<fpage>349</fpage>&#8211;<lpage>351</lpage>.<pub-id pub-id-type="pmid">14966142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.2003.029223</pub-id><pub-id pub-id-type="pmcid">PMC1738977</pub-id></mixed-citation></ref><ref id="awac463-B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Novak</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Markovic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Meymandi</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>DeGiorgio</surname><given-names>CM</given-names></string-name></person-group>. <article-title>Risk assessment for sudden death in epilepsy: The SUDEP-7 inventory</article-title>. <source>Front Neurol</source>. <year>2015</year>;<volume>6</volume>:<fpage>252</fpage>.<pub-id pub-id-type="pmid">26696953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2015.00252</pub-id><pub-id pub-id-type="pmcid">PMC4673971</pub-id></mixed-citation></ref><ref id="awac463-B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>DeGiorgio</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Meymandi</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group><article-title>RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: The SUDEP-7 inventory</article-title>. <source>Epilepsy Behav</source>. <year>2010</year>;<volume>19</volume>:<fpage>78</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">20667792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2010.06.011</pub-id><pub-id pub-id-type="pmcid">PMC2943000</pub-id></mixed-citation></ref><ref id="awac463-B11"><label>11</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>SUDEP Action</collab></person-group>. <date-in-citation content-type="access">SUDEP and Seizure Safety Checklist. Accessed 7 November 2018</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/347i8iY" ext-link-type="uri">https://bit.ly/347i8iY</ext-link></mixed-citation></ref><ref id="awac463-B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tarighati Rasekhi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Devlin</surname><given-names>KN</given-names></string-name>, <string-name name-style="western"><surname>Mass</surname><given-names>JA</given-names></string-name>, <etal>et al</etal></person-group><article-title>Improving prediction of sudden unexpected death in epilepsy: From SUDEP-7 to SUDEP-3</article-title>. <source>Epilepsia</source>. <year>2021</year>;<volume>62</volume>:<fpage>1536</fpage>&#8211;<lpage>1545</lpage>.<pub-id pub-id-type="pmid">34086290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.16928</pub-id></mixed-citation></ref><ref id="awac463-B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Walczak</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Leppik</surname><given-names>IE</given-names></string-name>, <string-name name-style="western"><surname>D&#8217;Amelio</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>:<fpage>519</fpage>&#8211;<lpage>525</lpage>.<pub-id pub-id-type="pmid">11222798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.56.4.519</pub-id></mixed-citation></ref><ref id="awac463-B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jha</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Oh</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hesdorffer</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group><article-title>Sudden unexpected death in epilepsy: A personalized prediction tool</article-title>. <source>Neurology</source>. <year>2021</year>;<volume>96</volume>:<fpage>e2627</fpage>&#8211;<lpage>e2638</lpage>.<pub-id pub-id-type="pmid">33910939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000011849</pub-id><pub-id pub-id-type="pmcid">PMC8205449</pub-id></mixed-citation></ref><ref id="awac463-B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Grant</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Nashef</surname><given-names>SAM</given-names></string-name></person-group>. <article-title>Statistical primer: Developing and validating a risk prediction model</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2018</year>;<volume>54</volume>:<fpage>203</fpage>&#8211;<lpage>208</lpage>.<pub-id pub-id-type="pmid">29741602</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ejcts/ezy180</pub-id></mixed-citation></ref><ref id="awac463-B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Collins</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Moons</surname><given-names>KG</given-names></string-name></person-group>. <article-title>Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>350</volume>:<fpage>g7594</fpage>.<pub-id pub-id-type="pmid">25569120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.g7594</pub-id></mixed-citation></ref><ref id="awac463-B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mbizvo</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Schnier</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>RFM</given-names></string-name></person-group>. <article-title>Validating the accuracy of administrative healthcare data identifying epilepsy in deceased adults: A Scottish data linkage study</article-title>. <source>Epilepsy Res</source>. <year>2020</year>;<volume>167</volume>:<comment>106462</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eplepsyres.2020.106462</pub-id><pub-id pub-id-type="pmid">32961444</pub-id></mixed-citation></ref><ref id="awac463-B18"><label>18</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>Chief Medical Officer</collab></person-group>. <comment>Guidance for Doctors Completing Medical Certificates of The Cause of Death (MCCD) and its Quality Assurance 2018</comment>. <date-in-citation content-type="access">Accessed 3 March 2020</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/2yyMzlC" ext-link-type="uri">https://bit.ly/2yyMzlC</ext-link></mixed-citation></ref><ref id="awac463-B19"><label>19</label><mixed-citation publication-type="other"><comment>National Records of Scotland. Death Certificates and Coding the Causes of Death 2017</comment>. <date-in-citation content-type="access">Accessed 31 July 2020</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/2DrrjR2" ext-link-type="uri">https://bit.ly/2DrrjR2</ext-link></mixed-citation></ref><ref id="awac463-B20"><label>20</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>National Records of Scotland</collab></person-group>. Some Specific Checks Carried Out on Deaths Data. <italic toggle="yes">Vital Events &#8211; Deaths &#8211; Background Information</italic> 2019. Accessed 5 September 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/2F50Gm6" ext-link-type="uri">https://bit.ly/2F50Gm6</ext-link></mixed-citation></ref><ref id="awac463-B21"><label>21</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>NHS Education for Scotland</collab></person-group>. <comment>Medical certification of cause of death. 2021</comment>. <date-in-citation content-type="access">Accessed 16 March 2022</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/3tZS8CO" ext-link-type="uri">https://bit.ly/3tZS8CO</ext-link></mixed-citation></ref><ref id="awac463-B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fernie</surname><given-names>CGM</given-names></string-name></person-group>. <article-title>Scotland already has world leading mortality review system</article-title>. <source>BMJ-Brit Med J</source>. <year>2019</year>;<volume>364</volume>:<fpage>l395</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.l395</pub-id><pub-id pub-id-type="pmid">30733310</pub-id></mixed-citation></ref><ref id="awac463-B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McKinstry</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sullivan</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Vasishta</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group><article-title>Cohort profile: The Scottish research register SHARE. A register of people interested in research participation linked to NHS data sets</article-title>. <source>BMJ Open</source>. <year>2017</year>;<volume>7</volume>:<comment>e013351</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2016-013351</pub-id><pub-id pub-id-type="pmcid">PMC5293989</pub-id><pub-id pub-id-type="pmid">28148535</pub-id></mixed-citation></ref><ref id="awac463-B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sullivan</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>McKinstry</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Vasishta</surname><given-names>S</given-names></string-name></person-group>. <article-title>The &#8220;all of us&#8221; research program</article-title>. <source>N Engl J Med</source>. <year>2019</year>;<volume>381</volume>:<fpage>1883</fpage>&#8211;<lpage>1884</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMc1912496</pub-id><pub-id pub-id-type="pmid">31693824</pub-id></mixed-citation></ref><ref id="awac463-B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kee</surname><given-names>VR</given-names></string-name>, <string-name name-style="western"><surname>Gilchrist</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Granner</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Sarrazin</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Carnahan</surname><given-names>RM</given-names></string-name></person-group>. <article-title>A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data</article-title>. <source>Pharmacoepidemiol Drug Safe</source>. <year>2012</year>;<volume>21</volume>:<fpage>183</fpage>&#8211;<lpage>193</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pds.2329</pub-id><pub-id pub-id-type="pmid">22262605</pub-id></mixed-citation></ref><ref id="awac463-B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fisher</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>van Emde Boas</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Blume</surname><given-names>W</given-names></string-name>, <etal>et al</etal></person-group><article-title>Epileptic seizures and epilepsy: Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)</article-title>. <source>Epilepsia</source>. <year>2005</year>;<volume>46</volume>:<fpage>470</fpage>&#8211;<lpage>472</lpage>.<pub-id pub-id-type="pmid">15816939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.0013-9580.2005.66104.x</pub-id></mixed-citation></ref><ref id="awac463-B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fisher</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Acevedo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Arzimanoglou</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group><article-title>ILAE Official Report: A practical clinical definition of epilepsy</article-title>. <source>Epilepsia</source>. <year>2014</year>;<volume>55</volume>:<fpage>475</fpage>&#8211;<lpage>482</lpage>.<pub-id pub-id-type="pmid">24730690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.12550</pub-id></mixed-citation></ref><ref id="awac463-B28"><label>28</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>Scottish Parliament Epilepsy Consortium Scotland</collab></person-group>. <comment>SUDEP rates remain high in Scotland. <italic toggle="yes">Cross Party Group Meeting</italic>. 2019</comment>. <date-in-citation content-type="access">Accessed 21 September 2020</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.epilepsyconsortiumscotland.co.uk/sudep-rates-scotland/" ext-link-type="uri">http://www.epilepsyconsortiumscotland.co.uk/sudep-rates-scotland/</ext-link></mixed-citation></ref><ref id="awac463-B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fyfe</surname><given-names>I</given-names></string-name></person-group>. <article-title>EAN Virtual 2020 - the largest neurology conference in history</article-title>. <source>Nat Rev Neurol</source>. <year>2020</year>;<volume>16</volume>:<fpage>404</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41582-020-0387-6</pub-id><pub-id pub-id-type="pmcid">PMC7330542</pub-id><pub-id pub-id-type="pmid">32616898</pub-id></mixed-citation></ref><ref id="awac463-B30"><label>30</label><mixed-citation publication-type="other"><comment>ERUK. ERUK Researcher Wins Award at ABN National Conference Epilepsy Research UK; 2019</comment>. <date-in-citation content-type="access">Accessed 19 May 2021</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/3bDanWa" ext-link-type="uri">https://bit.ly/3bDanWa</ext-link></mixed-citation></ref><ref id="awac463-B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Poupin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Bouleti</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Degand</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group><article-title>Prognostic value of Charlson Comorbidity Index in the elderly with a cardioverter defibrillator implantation</article-title>. <source>Int J Cardiol</source>. <year>2020</year>;<volume>314</volume>:<fpage>64</fpage>&#8211;<lpage>69</lpage>.<pub-id pub-id-type="pmid">32291172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2020.03.060</pub-id></mixed-citation></ref><ref id="awac463-B32"><label>32</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>Information Services Division</collab></person-group>. <comment>The Scottish Index of Multiple Deprivation (SIMD). <italic toggle="yes">GPD Support - Deprivation</italic>. ISD Scotland; 2016</comment>. <date-in-citation content-type="access">Accessed 27 October 2019</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/2V32ilM" ext-link-type="uri">https://bit.ly/2V32ilM</ext-link></mixed-citation></ref><ref id="awac463-B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Pompei</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ales</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>MacKenzie</surname><given-names>CR</given-names></string-name></person-group>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation</article-title>. <source>J Chronic Dis</source>. <year>1987</year>;<volume>40</volume>:<fpage>373</fpage>&#8211;<lpage>383</lpage>.<pub-id pub-id-type="pmid">3558716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0021-9681(87)90171-8</pub-id></mixed-citation></ref><ref id="awac463-B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Quan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Couris</surname><given-names>CM</given-names></string-name>, <etal>et al</etal></person-group><article-title>Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries</article-title>. <source>Am J Epidemiol</source>. <year>2011</year>;<volume>173</volume>:<fpage>676</fpage>&#8211;<lpage>682</lpage>.<pub-id pub-id-type="pmid">21330339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwq433</pub-id></mixed-citation></ref><ref id="awac463-B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Radovanovic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Seifert</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Urban</surname><given-names>P</given-names></string-name>, <etal>et al</etal></person-group><article-title>Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS plus registry 2002-2012</article-title>. <source>Heart</source>. <year>2014</year>;<volume>100</volume>:<fpage>288</fpage>&#8211;<lpage>294</lpage>.<pub-id pub-id-type="pmid">24186563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/heartjnl-2013-304588</pub-id></mixed-citation></ref><ref id="awac463-B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Elovic</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pourmand</surname><given-names>A</given-names></string-name></person-group>. <article-title>MDCalc medical calculator app review</article-title>. <source>J Digit Imaging</source>. <year>2019</year>;<volume>32</volume>:<fpage>682</fpage>&#8211;<lpage>684</lpage>.<pub-id pub-id-type="pmid">31025219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10278-019-00218-y</pub-id><pub-id pub-id-type="pmcid">PMC6737202</pub-id></mixed-citation></ref><ref id="awac463-B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kling</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ritvanen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mustonen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kamppi</surname><given-names>L</given-names></string-name></person-group>. <article-title>Long-term outcome of convulsive status epilepticus: A 10-year follow-up</article-title>. <source>Epileptic Disord.</source><year>1 2022</year>;<volume>24</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1684/epd.2022.1482</pub-id><pub-id pub-id-type="pmid">35993832</pub-id></mixed-citation></ref><ref id="awac463-B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kuswardhani</surname><given-names>RAT</given-names></string-name>, <string-name name-style="western"><surname>Henrina</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pranata</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Anthonius Lim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lawrensia</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Suastika</surname><given-names>K</given-names></string-name></person-group>. <article-title>Charlson Comorbidity Index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis</article-title>. <source>Diabetes Metab Syndr</source>. <year>2020</year>;<volume>14</volume>:<fpage>2103</fpage>&#8211;<lpage>2109</lpage>.<pub-id pub-id-type="pmid">33161221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dsx.2020.10.022</pub-id><pub-id pub-id-type="pmcid">PMC7598371</pub-id></mixed-citation></ref><ref id="awac463-B39"><label>39</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>eDRIS Team</collab></person-group>. <comment>Researcher guide: requesting outputs from Safe Haven and disclosure control 2018</comment>. <date-in-citation content-type="access">Accessed 16 November 2019</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bit.ly/2XzD1Bk" ext-link-type="uri">https://bit.ly/2XzD1Bk</ext-link></mixed-citation></ref><ref id="awac463-B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bujang</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Sa'at</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sidik</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Joo</surname><given-names>LC</given-names></string-name></person-group>. <article-title>Sample size guidelines for logistic regression from observational studies with large population: Emphasis on the accuracy between statistics and parameters based on real life clinical data</article-title>. <source>Malays J Med Sci</source>. <year>2018</year>;<volume>25</volume>:<fpage>122</fpage>&#8211;<lpage>130</lpage>.<pub-id pub-id-type="pmid">30914854</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21315/mjms2018.25.4.12</pub-id><pub-id pub-id-type="pmcid">PMC6422534</pub-id></mixed-citation></ref><ref id="awac463-B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peduzzi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Concato</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feinstein</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Holford</surname><given-names>TR</given-names></string-name></person-group>. <article-title>Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates</article-title>. <source>J Clin Epidemiol</source>. <year>1995</year>;<volume>48</volume>:<fpage>1503</fpage>&#8211;<lpage>1510</lpage>.<pub-id pub-id-type="pmid">8543964</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0895-4356(95)00048-8</pub-id></mixed-citation></ref><ref id="awac463-B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chowdhury</surname><given-names>MZI</given-names></string-name>, <string-name name-style="western"><surname>Turin</surname><given-names>TC</given-names></string-name></person-group>. <article-title>Variable selection strategies and its importance in clinical prediction modelling</article-title>. <source>Fam Med Community Health</source>. <year>2020</year>;<volume>8</volume>:<comment>e000262</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fmch-2019-000262</pub-id><pub-id pub-id-type="pmcid">PMC7032893</pub-id><pub-id pub-id-type="pmid">32148735</pub-id></mixed-citation></ref><ref id="awac463-B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McNeish</surname><given-names>D</given-names></string-name></person-group>. <article-title>Missing data methods for arbitrary missingness with small samples</article-title>. <source>J Appl Stat</source>. <year>2017</year>;<volume>44</volume>:<fpage>24</fpage>&#8211;<lpage>39</lpage>.</mixed-citation></ref><ref id="awac463-B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></string-name></person-group>. <article-title>How can I deal with missing data in my study?</article-title><source>Aust Nz J Publ Heal</source>. <year>2001</year>;<volume>25</volume>:<fpage>464</fpage>&#8211;<lpage>469</lpage>.<pub-id pub-id-type="pmid">11688629</pub-id></mixed-citation></ref><ref id="awac463-B45"><label>45</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>IBM</collab></person-group>. <comment>Method (Multiple Imputation). <italic toggle="yes">SPSS Statistics</italic>. 2021</comment>. <date-in-citation content-type="access">Accessed 19 May 2021.</date-in-citation><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ibm.co/3wjcMNw" ext-link-type="uri">https://ibm.co/3wjcMNw</ext-link></mixed-citation></ref><ref id="awac463-B46"><label>46</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Rubin</surname><given-names>DB</given-names></string-name></person-group>. <source>Multiple imputation for nonresponse in surveys</source>: <publisher-name>Wiley</publisher-name>; <year>1987</year>.</mixed-citation></ref><ref id="awac463-B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dong</surname><given-names>YR</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>CYJ</given-names></string-name></person-group>. <article-title>Principled missing data methods for researchers</article-title>. <source>Springerplus</source>. <year>2013</year>;<volume>2</volume>:<fpage>1</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="pmid">23853744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/2193-1801-2-222</pub-id><pub-id pub-id-type="pmcid">PMC3701793</pub-id></mixed-citation></ref><ref id="awac463-B48"><label>48</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Goodman</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Kruskal</surname><given-names>WH</given-names></string-name></person-group>. <source>Measures of association for cross classifications</source>: <publisher-name>Springer-Verlag</publisher-name>; <year>1979</year>.</mixed-citation></ref><ref id="awac463-B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Vergouwe</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Towards better clinical prediction models: Seven steps for development and an ABCD for validation</article-title>. <source>Eur Heart J</source>. <year>2014</year>;<volume>35</volume>:<fpage>1925</fpage>&#8211;<lpage>1931</lpage>.<pub-id pub-id-type="pmid">24898551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehu207</pub-id><pub-id pub-id-type="pmcid">PMC4155437</pub-id></mixed-citation></ref><ref id="awac463-B50"><label>50</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Harrell</surname><given-names>FE</given-names></string-name></person-group>. <source>Multivariable modeling strategies. Regression modeling strategies</source>. <publisher-name>Springer Chamonix</publisher-name>; <year>2015</year>.</mixed-citation></ref><ref id="awac463-B51"><label>51</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names></string-name></person-group>. <source>Clinical prediction models: A practical approach to development, validation, and updating</source>. <publisher-name>Springer</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="awac463-B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Noe</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Rosenbach</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hubbard</surname><given-names>RA</given-names></string-name>, <etal>et al</etal></person-group><article-title>Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis-ABCD-10</article-title>. <source>JAMA Dermatol</source>. <year>2019</year>;<volume>155</volume>:<fpage>448</fpage>&#8211;<lpage>454</lpage>.<pub-id pub-id-type="pmid">30840032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamadermatol.2018.5605</pub-id><pub-id pub-id-type="pmcid">PMC6459085</pub-id></mixed-citation></ref><ref id="awac463-B53"><label>53</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Dankers</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Traverso</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wee</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>van Kuijk</surname><given-names>SMJ</given-names></string-name></person-group>. <part-title>Prediction modeling methodology</part-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Kubben</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Dumontier</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dekker</surname><given-names>A</given-names></string-name></person-group>, eds. <source>Fundamentals of clinical data science</source>. <publisher-name>Springer</publisher-name>; <year>2019</year>:<fpage>101</fpage>&#8211;<lpage>120</lpage>.<pub-id pub-id-type="pmid">31314250</pub-id></mixed-citation></ref><ref id="awac463-B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Muschelli</surname><given-names>J</given-names></string-name></person-group>. <article-title>ROC And AUC with a binary predictor: A potentially misleading metric</article-title>. <source>J Classif</source>. <year>2019</year>;<volume>37</volume>:<fpage>696</fpage>&#8211;<lpage>708</lpage>.<pub-id pub-id-type="pmid">33250548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00357-019-09345-1</pub-id><pub-id pub-id-type="pmcid">PMC7695228</pub-id></mixed-citation></ref><ref id="awac463-B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mbizvo</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Larner</surname><given-names>AJ</given-names></string-name></person-group>. <article-title>Receiver operating characteristic plot and area under the curve with binary classifiers: Pragmatic analysis of cognitive screening instruments</article-title>. <source>Neurodegener Dis Manag</source>. <year>2021</year>;<volume>11</volume>:<fpage>353</fpage>&#8211;<lpage>360</lpage>.<pub-id pub-id-type="pmid">34569851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/nmt-2021-0013</pub-id></mixed-citation></ref><ref id="awac463-B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Moons</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>van der Windt</surname><given-names>DA</given-names></string-name>, <etal>et al</etal></person-group><article-title>Prognosis research strategy (PROGRESS) 3: Prognostic model research</article-title>. <source>PLoS Med</source>. <year>2013</year>;<volume>10</volume>:<comment>e1001381</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1001381</pub-id><pub-id pub-id-type="pmcid">PMC3564751</pub-id><pub-id pub-id-type="pmid">23393430</pub-id></mixed-citation></ref><ref id="awac463-B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dickson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Jacques</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Reuber</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Emergency hospital care for adults with suspected seizures in the NHS in England 2007-2013: A cross-sectional study</article-title>. <source>BMJ Open</source>. <year>2018</year>;<volume>8</volume>:<comment>e023352</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2018-023352</pub-id><pub-id pub-id-type="pmcid">PMC6196871</pub-id><pub-id pub-id-type="pmid">30344177</pub-id></mixed-citation></ref><ref id="awac463-B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dixon</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Kirkham</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Marson</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Pearson</surname><given-names>MG</given-names></string-name></person-group>. <article-title>National audit of seizure management in hospitals (NASH): Results of the national audit of adult epilepsy in the UK</article-title>. <source>BMJ Open</source>. <year>2015</year>;<volume>5</volume>:<comment>e007325</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2014-007325</pub-id><pub-id pub-id-type="pmcid">PMC4386236</pub-id><pub-id pub-id-type="pmid">25829372</pub-id></mixed-citation></ref><ref id="awac463-B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mathieson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Marson</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Clinically unnecessary and avoidable emergency health service use for epilepsy: A survey of what English services are doing to reduce it</article-title>. <source>Seizure</source>. <year>2020</year>;<volume>76</volume>:<fpage>156</fpage>&#8211;<lpage>160</lpage>.<pub-id pub-id-type="pmid">32092677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.seizure.2020.02.012</pub-id></mixed-citation></ref><ref id="awac463-B60"><label>60</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Ridsdale</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>McCrone</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Morgan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goldstein</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Seed</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Noble</surname><given-names>A</given-names></string-name></person-group>. <comment>Can an epilepsy nurse specialist-led self-management intervention reduce attendance at emergency departments and promote well-being for people with severe epilepsy? A non-randomised trial with a nested qualitative phase. Health Services and Delivery Research; 2013</comment>.<pub-id pub-id-type="pmid">25642529</pub-id></mixed-citation></ref><ref id="awac463-B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Noble</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Mathieson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ridsdale</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group><article-title>Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: Protocol for the mixed-methods observational &#8216;collaborate&#8217; project</article-title>. <source>BMJ Open</source>. <year>2019</year>;<volume>9</volume>:<comment>e031696</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2019-031696</pub-id><pub-id pub-id-type="pmcid">PMC6830638</pub-id><pub-id pub-id-type="pmid">31678950</pub-id></mixed-citation></ref><ref id="awac463-B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wojewodka</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Gulliford</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Ashworth</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Richardson</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Ridsdale</surname><given-names>L</given-names></string-name></person-group>. <article-title>Epilepsy and mortality: A retrospective cohort analysis with a nested case-control study identifying causes and risk factors from primary care and linkage-derived data</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>:<comment>e052841</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2021-052841</pub-id><pub-id pub-id-type="pmcid">PMC8547505</pub-id><pub-id pub-id-type="pmid">34697121</pub-id></mixed-citation></ref><ref id="awac463-B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mercado</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gonzalez</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Vargas</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group><article-title>Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2014</year>;<volume>99</volume>:<fpage>4438</fpage>&#8211;<lpage>4446</lpage>.<pub-id pub-id-type="pmid">25210882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jc.2014-2670</pub-id></mixed-citation></ref><ref id="awac463-B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Levira</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Thurman</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Sander</surname><given-names>JW</given-names></string-name>, <etal>et al</etal></person-group><article-title>Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the mortality task force of the international league against epilepsy</article-title>. <source>Epilepsia</source>. <year>2016</year>;<volume>56</volume>:<fpage>6-</fpage><lpage>16</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.13603</pub-id><pub-id pub-id-type="pmcid">PMC7012644</pub-id><pub-id pub-id-type="pmid">27988968</pub-id></mixed-citation></ref><ref id="awac463-B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lyons</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nafilyan</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Akbari</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group><article-title>Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK</article-title>. <source>Int J Popul Data Sci</source>. <year>2020</year>;<volume>5</volume>:<fpage>1697</fpage>.<pub-id pub-id-type="pmid">35310465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.23889/ijpds.v5i4.1697</pub-id><pub-id pub-id-type="pmcid">PMC8900650</pub-id></mixed-citation></ref><ref id="awac463-B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lyons</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>John</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group><article-title>The SAIL databank: Linking multiple health and social care datasets</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2009</year>;<volume>9</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">19149883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6947-9-3</pub-id><pub-id pub-id-type="pmcid">PMC2648953</pub-id></mixed-citation></ref><ref id="awac463-B67"><label>67</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Levy</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Buckingham</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Evans</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Francis</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Houston</surname><given-names>R</given-names></string-name></person-group>. <comment>Confidential Enquiry report. Why asthma still kills: The National Review of Asthma Deaths (NRAD) 2014</comment>. <date-in-citation content-type="access">Accessed 19 August 2022</date-in-citation>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf" ext-link-type="uri">www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf</ext-link></mixed-citation></ref><ref id="awac463-B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wood</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Denholm</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hollings</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group><article-title>Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: Data resource</article-title>. <source>BMJ-Brit Med J</source>. <year>2021</year>;<volume>373</volume>:<fpage>n826</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n826</pub-id><pub-id pub-id-type="pmcid">PMC8413899</pub-id><pub-id pub-id-type="pmid">33827854</pub-id></mixed-citation></ref><ref id="awac463-B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buckley</surname><given-names>BJR</given-names></string-name>, <string-name name-style="western"><surname>Harrison</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Underhill</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lane</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Lip</surname><given-names>GYH</given-names></string-name></person-group>. <article-title>Stroke-heart syndrome: Incidence and clinical outcomes of cardiac complications following stroke</article-title>. <source>Stroke</source>. <year>2022</year>;<volume>53</volume>:<fpage>1759</fpage>&#8211;<lpage>1763</lpage>.<pub-id pub-id-type="pmid">35354300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.121.037316</pub-id></mixed-citation></ref><ref id="awac463-B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O'Neill</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kalia</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aliarzadeh</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group><article-title>Cardiovascular risk factor documentation and management in primary care electronic medical records among people with schizophrenia in Ontario. Canada: Retrospective cohort study</article-title>. <source>BMJ Open</source>. <year>2020</year>;<volume>10</volume>:<comment>e038013</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2020-038013</pub-id><pub-id pub-id-type="pmcid">PMC7569984</pub-id><pub-id pub-id-type="pmid">33067284</pub-id></mixed-citation></ref><ref id="awac463-B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Franzen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Janson</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Larsson</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group><article-title>Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: The PACEHR study</article-title>. <source>Respir Res</source>. <year>2016</year>;<volume>17</volume>:<fpage>152</fpage>.<pub-id pub-id-type="pmid">27842551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-016-0461-1</pub-id><pub-id pub-id-type="pmcid">PMC5109788</pub-id></mixed-citation></ref><ref id="awac463-B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Haas</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Ruffieux</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>van den Heuvel</surname><given-names>LL</given-names></string-name>, <etal>et al</etal></person-group><article-title>Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: A cohort study using linked electronic health records</article-title>. <source>Lancet Glob Health</source>. <year>2020</year>;<volume>8</volume>:<fpage>e1326</fpage>&#8211;<lpage>e1334</lpage>.<pub-id pub-id-type="pmid">32971055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2214-109X(20)30279-5</pub-id><pub-id pub-id-type="pmcid">PMC7582785</pub-id></mixed-citation></ref><ref id="awac463-B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Luczak</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kalinowski</surname><given-names>S</given-names></string-name></person-group>. <article-title>Assessing the level of the material deprivation of European Union countries</article-title>. <source>PLoS ONE</source>. <year>2020</year>;<volume>15</volume>:<comment>e0238376</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0238376</pub-id><pub-id pub-id-type="pmcid">PMC7467282</pub-id><pub-id pub-id-type="pmid">32877467</pub-id></mixed-citation></ref><ref id="awac463-B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Rossi</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Jette</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Yoo</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Hung</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Dhamoon</surname><given-names>MS</given-names></string-name></person-group>. <article-title>Increased risk of hospital admission for mood disorders following admission for epilepsy</article-title>. <source>Neurology</source>. <year>2018</year>;<volume>91</volume>:<fpage>e800</fpage>&#8211;<lpage>e810</lpage>.<pub-id pub-id-type="pmid">30068636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.wnl.0000542492.00605.9d</pub-id></mixed-citation></ref><ref id="awac463-B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Leung</surname><given-names>WCY</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>EHY</given-names></string-name>, <string-name name-style="western"><surname>Kwan</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>RS</given-names></string-name></person-group>. <article-title>Impact of COVID-19 on seizure-related emergency attendances and hospital admissions &#8211; A territory-wide observational study</article-title>. <source>Epilepsy Behav</source>. <year>2021</year>;<volume>115</volume>:<comment>107497</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2020.107497</pub-id><pub-id pub-id-type="pmcid">PMC7505596</pub-id><pub-id pub-id-type="pmid">33317939</pub-id></mixed-citation></ref><ref id="awac463-B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Navaratnam</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>WK</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wendon</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Briggs</surname><given-names>TWR</given-names></string-name></person-group>. <article-title>Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: An observational study using administrative data</article-title>. <source>Lancet Respir Med</source>. <year>2021</year>;<volume>9</volume>:<fpage>397</fpage>&#8211;<lpage>406</lpage>.<pub-id pub-id-type="pmid">33600777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30579-8</pub-id><pub-id pub-id-type="pmcid">PMC7906650</pub-id></mixed-citation></ref><ref id="awac463-B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Johnston</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Nguyen-Huynh</surname><given-names>MN</given-names></string-name>, <etal>et al</etal></person-group><article-title>Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>369</volume>:<fpage>283</fpage>&#8211;<lpage>292</lpage>.<pub-id pub-id-type="pmid">17258668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)60150-0</pub-id></mixed-citation></ref><ref id="awac463-B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pei</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname><given-names>H</given-names></string-name>, <etal>et al</etal></person-group><article-title>Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>:<fpage>19132</fpage>.<pub-id pub-id-type="pmid">33154471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-75666-6</pub-id><pub-id pub-id-type="pmcid">PMC7644691</pub-id></mixed-citation></ref><ref id="awac463-B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kappen</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>van Klei</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>van Wolfswinkel</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kalkman</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Vergouwe</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Moons</surname><given-names>KGM</given-names></string-name></person-group>. <article-title>Evaluating the impact of prediction models: Lessons learned, challenges, and recommendations</article-title>. <source>Diagn Progn Res</source>. <year>2018</year>;<volume>2</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">31093561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s41512-018-0033-6</pub-id><pub-id pub-id-type="pmcid">PMC6460651</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>